Section 34

EurekaMag PDF full texts Chapter 33,363


Feldman, H.H.; Kennard, M.L.; Sauter, A.H.; Tam, S.; Devonshire, V.A.; Anderson, D.P.; Jefferies, W.A. 1997: Serum p97 concentration but not tropicamide pupillary response identifies Alzheimers disease. Neurology 48(3 Suppl 2): A378
Linder, R.; Sziegoleit, A.; Peters, B.; Brattström, C.; Tydén, G.; Groth, C.G. 1990: Serum pancreatic elastase 1 as a marker of pancreatic graft damage. Transplantation Proceedings 22(4): 1595
Billi, P.; Pezzilli, R.; Cursaro, C.; Andreone, P.; Barakat, B.; Gramenzi, A.; Fiocchi, M.; Miglio, F. 1997: Serum pancreatic enzyme concentrations in chronic viral liver diseases. Gastroenterology 112(4 Suppl): A1227
Basso D.; Angonese C.; Fabris C.; Meggiato T.; Del Favero G.; Fogar P.; Panozzo M.P.; Scalon P.; Plebani M.; Et Al 1990: Serum pancreatic enzymes are less accurate than fluorescein dilaurate test in detecting exocrine pancreatic insufficiency. Medical Science Research 18(6): 229-230
Pezzilli, R.; Gullo, L.; Ricchi, E.; Fontana, G. 1990: Serum pancreatic enzymes in hiv positive patients. Digestion 46(3): 169-170
Masoero, G.; Bruno, M.; Gallo, L.; Colaferro, S.; Cosseddu, D.; Vacha, G.M. 1994: Serum pancreatic enzymes in renal failure. Digestion 55(5): 316
Yamamoto, K.; Shinomura, Y.; Tojo, H.; Okamoto, M.; Tarui, S. 1993: Serum pancreatic phospholipase A2 and prophospholipase A2 in acute pancreatitis and after endoscopic retrograde pancreatography. Gastroenterologia Japonica 28(5): 679-686
Suzuki, Y.; Kuroda, Y.; Fujino, Y.; Fujiwara, H.; Kawamura, T.; Saitoh, Y. 1990: Serum pancreatic secretory trypsin inhibitor monitoring for early diagnosis of pancreas allograft rejection in dogs. Transplantation Proceedings 22(2): 704-706
Deenmamode, M.J.M.J.; Nicholl, R.M.; Gamsu, H.R.; Sherwood, R.A. 1998: Serum pancreatitis associated protein in preterm neonates. Digestion 59(3): 265
Nordback, I.; Jaakkola, M.; Iovanna, J.L.; Dagorn, J.C. 1993: Serum pancreatitis-associated protein increases after long-term heavy drinking. Digestion 54(5): 297
Lock, G.; Kadow, R.; Messmann, H.; Schoelmerich, J.; Holstege, A. 1996: Serum pancreolauryl test in chronic pancreatitis Comparison to ERCP. Gastroenterology 110(4 Suppl): A413
Masek, T.; Severin, K.; Horvatek, D.; Janicki, Z.; Konjevic, D.; Slavica, A.; Mikulec, Z. 2000: Serum parameters of intensively reared common pheasant Phisianus colchicus during fattening. Archiv fuer Gefluegelkunde 71(3): 135-138
Del Colle, R.; De Fanti, E.; Turazzini, M.; Battaglia, P.; Silvestri, M.; Targa, L.; Schiavon, R. 1997: Serum paraoxonase activity is an independent risk factor for stroke Comparison with homocystein, fibrinogen and lipoprotein parameters. Journal of the Neurological Sciences 150(Suppl ): S84
Cooke, C.J.; Hama, S.Y.; Van Lenten, B.J.; Fukumoto, L.; Southaphanh, P.; Navab, M.; Miller, N.E.; Fogelman, A.M. 1998: Serum paraoxonase activity, lecithin cholesterol acyltransferase activity and cholesterol efflux following apolipoprotein A-I infusion in humans. Circulation 98(17): I252
Pavković, E.; Simeon, V.; Reiner, E.; Sućić, M.; Lipovac, V. 1993: Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders. Chemico-Biological Interactions 87(1-3): 179-182
Shih, D.M.; Gu, L.; Navab, M.; Hama, S.Y.; Fogelman, A.M.; Lusis, A.J. 1995: Serum paraoxonase levels are regulated by diet and genetic studies suggest a link to atherosclerosis. Circulation 92(8): I163-I164
Li, W.F.; Costa, L.G.; Furlong, C.E. 1993: Serum paraoxonase status: a major factor in determining resistance to organophosphates. Journal of Toxicology and Environmental Health 40(2-3): 337-346
Bademkiran,S.; Yokus,B.; Cakir,D.U.; Durak,M.H.; Kurt,D. 2008: Serum paraoxonase-1 activity in dairy cattle and its association with dystocia. Journal Of Animal And Veterinary Advances: 10, 1184-1189
Cecchin, E.; De Marchi, S.; Turrin, D.; Guerra, U.P.; Bartoli, E. 1993: Serum parathyroid hormone and renal handling of calcium and magnesium during acute volume expansion in primary aldosteronism. Nephrology Dialysis Transplantation 8(9): 936
O'donnell, M.J.; Giles, P.; Hayer, A.; Constable, T. 1994: Serum parathyroid hormone and vitamin D levels in Asian patients presenting to a rheumatology clinic. Clinical Science 86(2): 21P-22P
Probst, W.; Fischer, J.A.; Binswanger, U. 1990: Serum parathyroid hormone concentration after intravenous 1 25 dihydroxyvitamin d 3 treatment in hemodialysis patients. Kidney International 37(4): 1177
St John, A.; Hoad, K.; Mallon, D.; French, M. 1995: Serum parathyroid hormone concentrations in patients with HIV infection. Annals of Clinical Biochemistry 32: 94-95
Manimekalai, S.; Unni, S.; Sundaram, K.S.; Goldstein, P.J. 1989: Serum parathyroid hormone in hemodialysis patients. Clinical Chemistry 35(6): 1140
Salusky, I.B.; Juppner, H.; Segre, G.V.; Goodman, W.G. 1995: Serum parathyroid hormone levels as a predictor of the skeletal response to intermittent calcitriol therapy. Journal of the American Society of Nephrology 6(3): 940
Gilquin, J.; Piketty, C.; Kitzis, M.D.; Cormier, P.; Kazatchkine, M.D.; Acar, J.F. 1996: Serum paromomycin levels in AIDS patients treated for cryptosporidiosis. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol One One world: One hope : 320-321
Shihabi, Z.K. 1993: Serum pentobarbital assay by capillary electrophoresis. Journal of Liquid Chromatography 16(9-10): 2059-2068
Shihabi, Z.K. 1992: Serum pentobarbital determination by capillary electrophoresis. Clinical Chemistry 38(6): 1008-1009
Vianello, F.; Plebani, M.; Dotto, P.; Ferrana, M.; Dal Bo', N.; Del Bianco, T.; Salandin, S.; Faggian, D.; Leandro, G.; Battaglia, G.; Di Mario, F. 1994: Serum pepsinogen A and C An useful marker of Helicobacter pylori eradication. Gastroenterology 106(4 Suppl): A200
Vianello, F.; Ferrana, M.; Di Mario, F.; Plebani, M.; Dal Bo, N.; Salandin, S.; Rugge, M.; Vigneri, S.; Del Bianco, T. 1994: Serum pepsinogen A and C evaluation in a 6-months follow-up of HP eradication. American Journal of Gastroenterology 89(8): 1389
Ferrana, M.; Di Mario, F.; Vianello, F.; Battaglia, G.; Kusstatscher, S.; Grasso, G.A.; Basso, D.; Rugge, M.; Plebani, M. 1995: Serum pepsinogen A and C levels A follow-up study on 476 patients after Helicobacter pylori eradication. Gastroenterology 108(4 Suppl): A93
Testino, G. 1994: Serum pepsinogen a and pepsin secretion in duodenal ulcer: Helicobacter pylori influence. Acta Gastroenterologica Latinoamericana 24(3): 149-152
Sabbatini, F.; D'argenio, G.; Ciacci, C.; Iovino, P.; Toso, S.; Mazzacca, G. 1993: Serum pepsinogen A levels during the long-term course of duodenal ulcer disease. Gastroenterology 104(4 Suppl): A183
Poletti, M.; Testino, G.; De Iaco, F. 1993: Serum pepsinogen A levels in patients with esophagitis, in patients with isolated duodenal ulcer and in control subjects. Gastroenterology 104(4 Suppl): A173
Roma, E.; Louiti, E.; Panayiotou, J.; Barbati, C.; Charissiadou, A.; Constantopoulos, A.; Kattamis, C. 1997: Serum pepsinogen I in children with gastritis. Pediatric Research 42(3): 395
Tokieda, M.; Fujioka, T.; Kubota, T.; Murakami, K.; Takahashi, K.; Nasu, M. 1996: Serum pepsinogen I/II ratio as realtime non-invasive marker of response to cure of H pylori infection. Gastroenterology 110(4 Suppl): A279
Axelsson, C.K.; Szecsi, P.B.; Hansen, I.M.; Lundborg, C.J.; Nielsen, M.D. 1989: Serum pepsinogen a and c in campylobacter pylori associated gastritis. Scandinavian Journal of Gastroenterology Suppl 24(159): 38
Veenendaal, R.A.; Biemond, I.; Pena, A.S.; Kreuning, J.; Lamers, C.B.H.W. 1991: Serum pepsinogen a and c values before and after treatment of helicobacter pylori infection. Gut 32(10): A1207
Hengels, K.J.; Peters, J.; Born, A.; Muenzel, P.; Zeidler, H. 1989: Serum pepsinogen c pgc on therapy with nonsteroidal antiinflammatory drugs nsaid changes are drug related and depend on gastric mucosal histology. Gastroenterology 96(5 Part 2): A205
Truesdale, R.A.; Samloff, I.M.; Chamberlain, C.E.; Maydonovitch, C.L.; Peura, D.A.; Wong, R.K.H. 1992: Serum pepsinogen i and ii levels reflect the status of helicobacter pylori infection and response the treatment. Gastroenterology 102(4 Part 2): A180
Humbert, P.; Salva, J.A.; Pique, J.M.; Planas, R.; Cabre, E.; Fernandez Banares, F.; Guilera, M.; Gassull, M.A. 1990: Serum pepsinogen i response to modified sham feeding test in recurrent duodenal ulcer after vagotomy and drainage. Gastroenterology 98(5 Part 2): A62
Kodoi, A.; Yoshihara, M.; Sumii, K.; Haruma, K.; Kajiyama, G. 1995: Serum pepsinogen in screening for gastric cancer. Journal of Gastroenterology 30(4): 452-460
Suzuki, M.; Suzuki, H.; Mori, M.; Kitahora, T.; Ishii, H. 1998: Serum pepsinogen level is associated with corpus neutrophil infiltration in H pylori-infected stomach. Gastroenterology 114(4 Part 2): A299
Lai, K.C.; Ching, C.K.; Wong, B.C.Y.; Hu, H.W.C.; Ong, L.Y.; Gao, Z.; Chen, J.S.; Chen, B.W.; Jiang, X.W.; Hou, X.H.; Lu, J.Y.; Wang, Q.H.; Hui, W.M.; Miki, K.; Lam, S.K. 1997: Serum pepsinogen levels in different gastroduodenal lesions and in subjects from two areas with contrasting gastric cancer rates. Gastroenterology 112(4 Suppl): A599
D.M.rio, F.; Dal Bo, N.; Battaglia, G.; Pilotto, A.; Vianello, F.; Basso, D.; Vigneri, S.; Savarino, V.; Plebani, M.; Rugge, M. 1998: Serum pepsinogens A and C in monitoring Helicobacter pylori status after the cure A prospective 4 year study. Gastroenterology 114(4 Part 2): A104-A105
D.M.rio, F.; Dal Bo, N.; Battaglia, G.; Salandin, S.; Buda, A.; Pilotto, A.; Vianello, F.; Basso, D.; Vigneri, S.; Savarino, V.; Plebani, M.; Rugge, M. 1998: Serum pepsinogens A and C in monitoring Helicobacter pylori status after the cure A prospective 4 years study. Gut 43(Suppl 2): A99
Biemond, I.; Veenendaal, R.A.; Ligthart, G.J.; Lamers, C.B.H.W. 1994: Serum pepsinogens and Helicobacter pylori infection in elderly patients. Gastroenterology 106(4 Suppl): A52
Koo, J.Y.; Park, S.P. 1995: Serum pepsinogens and antibody to Helicobacter pylori in gastric diseases. Gastroenterology 108(4 Suppl): A492
Shirai, N.; Furuta, T.; Sugimoto, M.; Kanaoka, S.; Watanabe, F.; Takashima, M.; Yamada, M.; Futami, H.; Sato, Y.; Kubota, H.; Kodaira, M.; Kajimura, M.; Maekawa, M.; Hishida, A. 2008: Serum pepsinogens as an early diagnostic marker of H. pylori eradication. Hepato-Gastroenterology 55(82-83): 486-490
Hunter, F.; Correa, P.; Fontham, E.; Ruiz, B.; Sobhan, M.; Samloff, M. 1991: Serum pepsinogens as markers response to therapy for helicobacter pylori gastritis. Clinical Research 39(4): 805A
Vianello, F.; Basso, D.; Dotto, P.; Battaglia, G.; Dal Bo, N.; Salandin, S.; Ferrana, M.; Grasso, G.A.; Del Bianco, T. 1994: Serum pepsinogens as predictors of H pylori eradication and bacterial load. American Journal of Gastroenterology 89(8): 1390
Hengels, K.J.; Jablonowski, H.; Porschen, R.; Strohmeyer, G. 1992: Serum pepsinogens in patients with gastritis and duodenal ulcer disease. Gastroenterology 102(4 Part 2): A81
You, C.W.; Blot, W.J.; Chang, Y.S.; Kneller, R.; Zhang, L.; Zhao, L.; Samloff, M.I. 1993: Serum pepsinogens in relation to precancerous gastric lesions and other factors in a population at high risk for stomach cancer. American Journal of Epidemiology 138(8): 625-626
Hengels, K.J.; Cooreman, M.; Schumacher, B.; Porschen, R.; Borchard, F.; Strohmeyer, G. 1990: Serum pepsinogens sensitive indicators of gastritis activity. Gastroenterology 98(5 Part 2): A57
Bhaduri, S.; Florence, L.; Artero, M.; Ross, K.; Brennan, D.; Winklhofer, F.; Mccarthy, E.; Sharma, R.; Abrams, J.; Diederich, D.; Lewis, R.; Strom, T.; Vincenti, F.; Savin, V. 1997: Serum permeability activity predicts outcome of therapy to prevent allograft loss in focal segmental glomerulo-sclerosis. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 710A
Jiang, F.; Grenier, J.; Lilge, L.; Amin, N.B.; Anandan, J.V.; Chopp, M. 1998: Serum pharmacokinetics and tissue distribution of photofrin in nude rat bearing human U87 glioma. Photochemistry and Photobiology 67(SPEC ISSUE): 101S
Heinemann, V.; Jehn, U.; Gleixner, B.; Wachholz, W.; Scholz, P.; Kolb, H.J. 1992: Serum pharmacokinetics of liposomal amphotericin B. Annals of Hematology 65(Suppl ): A67
Marko, E.; Horvath, A.; Pap, V.; Kovacs, G.L. 1990: Serum phenobarbital primidone ratio in adult and pediatric epileptic patients. Clinical Chemistry 36(6): 1035
Lind, L.; Lithell, H.; Ljunghall, S. 1991: Serum phosphate and blood pressure. Journal of Hypertension 9(Suppl 6): S459
Hasbargen, J.A.; Hasbargen, B.J. 1992: Serum phosphate po 4 levels vary during peritoneal equilibration tests pet in continuous ambulatory peritoneal dialysis capd patients. Journal of the American Society of Nephrology 3(3): 411
Komatsubara, T.; Tojo, H.; Ying, Z.; Tomita, T.; Ochi, T.; Okamoto, M. 1995: Serum phospholipase A2 activity and immunoreactive group Ii phospholipase A2 in rheumatoid arthritis. Clinica Chimica Acta; International Journal of Clinical Chemistry 236(1): 109-112
Nevalainen, T.J.; Gronroos, J.M. 1997: Serum phospholipase A-2 in inflammatory diseases. Uhl, W, Nevalainen, T J, Buechler, M W Progress in Surgery; Phospholipase A2: Basic and clinical aspects in inflammatory diseases: 104-109
Hoffmann, G.E.; Hiefinger, R.; Steinbrueckner, B. 1989: Serum phospholipase A in hospitalized patients. Clinica Chimica Acta; International Journal of Clinical Chemistry 183(1): 59-64
Winslet, M.C.; Hall, C.; Hendrickse, C.; Lawson, N.; Neoptolemos, J. 1991: Serum phospholipase A2 and free fatty acid levels in acute pancreatitis. Biochemical Society Transactions 19(2): 225s
Kates, D.M.; Sherrard, D.J.; Andress, D.L. 1995: Serum phosphorus strongly correlates with PTH in mild chronic renal failure. Journal of the American Society of Nephrology 6(3): 965
Bundred, N.J.; Harding, C.; Mcmichael, P.D.; Howell, A.; Morton, M. 1998: Serum phytoestrogen concentrations in British women with breast cancer and controls. American Journal of Clinical Nutrition 68(6 Suppl): 1529S-1530S
Glueck, C.J.; Speirs, J.; Tracy, T. 1991: Serum phytosterols cholesterol and premature coronary heart disease. Clinical Research 39(2): 253A
Elomaa, I.; Blomqvist, C.; Karaharju, E.; Laasonen, E.; Holstrom, T.; Risteli, L.; Risteli, J. 1989: Serum piiinp a novel tumor marker in osteosarcoma. Calcified Tissue International 44(Suppl): S9
Rush, D.; Hamiwka, L.; Walker, S.; Perry, Y.; Jeffery, J.; Bose, R.; Bolli, P. 1995: Serum platelet-derived growth factor in cyclosporine -treated renal transplant patients Correlation with parathyroid hormone and cholesterol levels. Journal of the American Society of Nephrology 6(3): 1113
Barsoum, A.L.; Kurl, R.N. 1991: Serum poly a polymerase activity in rats during development of 7 12 dimethylbenz a anthracene induced mammary tumors. Proceedings of the American Association for Cancer Research Annual Meeting 32: 84
Moysich, K.B.; Ambrosone, C.B.; Vena, J.E.; Kostyniak, P.; Shields, P.G.; Marshall, J.R.; Graham, S.; Laughlin, R.; Greizerstein, H.; Freudenheim, J.L. 1997: Serum polychlorinated biphenyls and postmenopausal breast cancer risk. Proceedings of the American Association for Cancer Research Annual Meeting 38: 627
Nomura, N.; Fotiades, J.; Lim, H.W.; Sassa, S.; Zolla Pazner, S.; Simberkoff, M. 1995: Serum porphyrin profile in patients with HIV infection. Journal of Investigative Dermatology 104(4): 654
Boden Albala, B.; Sacco, R.L.; Lin, I Feng; Abel, G.A.; Kargman, D.E.; Elkind, M.; Paik, M.C. 1998: Serum potassium an ischemic stroke risk Findings from the Northern Manhattan Stroke Study. Stroke 29(1): 278
Calhoun, K.A. 1990: Serum potassium concentration abnormalities. Critical Care Nursing Quarterly 13(3): 34-38
Earl, L.K.; Kesingland, K.; Davis, K.P.; Dayan, A.D. 1990: Serum potentiation of allylamine toxicity in vitro. Human and Experimental Toxicology 9(5): 358
Zarski, J.P.; Thelu, M.A.; Budkowska, A.; Bichard, P.; Rahail, M.; Seigneurin, J.M. 1990: Serum pre s1 pre s2 markers and hbv dna detected by polymerase chain reaction pcr in chronic b hepatitis during interferon therapy with favorable response. Journal of Hepatology 11(Suppl 2): S119
Maru, M.; Goldwasser, P. 1997: Serum prealbumin and proteinuria. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 72A
Singh, J.; Kulig, K.; Dudley, A.W.Jr; Lucco, L. 1989: Serum prealbumin levels in normal individuals of various age and in patients with acquired immunodeficiency syndrome aids. Clinical Chemistry 35(6): 1115
Dalphin, J.C.; Toson, B.; Monnet, E.; Pernet, D.; Dubiez, A.; Aiache, J.M.; Depierre, A. 1992: Serum precipitins against farmers lung fl antigens in the french region of the doubs prevalence and relation to the disease. American Review of Respiratory Disease 145(4 Part 2): A492
Khanna, P.; Pearlman, F. 1989: Serum pretreatment in digoxin immunoassay us patent 4798804 january 17 1989. Official Gazette of the United States Patent and Trademark Office Patents 1098(3): 1458-1459
Pest, P.S.; Corti, R.; Pedrana, R.; Varela, A.; Glancszpigel, R.; Schraier, M. 1998: Serum prevalence of Helicobacter pylori in blood banks and healthy children, its relationship with gender, age, socio-economic level, sanitary infrastructure and the geographical area in the Argentine Republic. Gastroenterology 114(4 Part 2): A257
Queiros, L.; Condeco, J.; Tender, A.; Mateus, M.; Texeira, A.; Pascoal, H. 1998: Serum prevalence of antibodies for Hepatitis E Virus in a population of donors. Vox Sanguinis 74(Suppl 1): 1147
Ramsell, K.D.; Cobbett, P. 1995: Serum prevents stellation of cultured pituicytes induced by cyclic nucleotide. Society for Neuroscience Abstracts 21(1-3): 1871
Okahara, S.; Sumii, K.; Sumii, M.; Kamiyasu, T.; Hamada, M.; Yamauchi, R.; Nojima, K.; Tanaka, S.; Yoshihara, M.; Haruma, K.; Kajiyama, G. 1996: Serum pro-gastrin-releasing peptide in subjects with or without Helicobacter pylori infection. Gastroenterology 110(4 Suppl): A217
Koca, S.S.; Isik, A.; Ustundag, B.; Metin, K.; Aksoy, K. 2008: Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus. Inflammation 31(3): 146-153
Taylor, D.J.; Cheung, N.; Dawes, P.; Fenner, H.; Hasler, F. 1994: Serum proMMP-3 A potential marker of synovial monokine activity in rheumatoid joints. Arthritis and Rheumatism 37(9 Suppl): S194
Becker, K.L.; White, J.C.; Steinwald, P.; Nylen, E.; Snider, R.; Simon, G.; Goldberg, R.; Whang, K. 1997: Serum procalcitonin predicts survival in sepsis. Journal of Endocrinology 152(Suppl ): P145
Shirai, T.; Umeda, M.; Anno, S.; Kosuge, T.; Katoh, M.; Moro, S.; Su, C.Y.; Shikoshi, K.; Arai, N. 1992: Serum procollagen III peptide, type IV collagen 7S prolylhydroxylase in myeloproliferative disorders. Annals of Hematology 65(Suppl ): A125
Luisetti, M.; Bulgheroni, A.; Bacchella, L.; Aprile, C.; Pasturenzi, L.; Gualtieri, G.; Peona, V. 1990: Serum procollagen iii aminopeptide in the assessment of sarcoidosis. American Review of Respiratory Disease 141(4 Part 2): A317
Luisetti M.; Donnini M.; Dyne K.; Bacchella L.; Aprile C.; De Rose V.; Cetta G.; Pozzi E. 1989: Serum procollagen iii aminopeptide levels in diffuse pulmonary fibrosis reflect lung total collagen content. American Review of Respiratory Disease 139(4 Part 2): A471
Vargas C.A.; Jeffers L.; Civantos F.; Cheinquer H.; Molina E.; De Medina M.; Hill M.; Larue S.; Radick J.; Et Al 1992: Serum procollagen iii peptide in chronic viral c hepatitis and its correlation with aminotransferase levels and liver histology in the assessment of disease activity and cirrhosis. Gastroenterology 102(4 Part 2): A905
Siciliano, M.; Lorenzin, F.; Milani, A.; Marra, L.; Rossi, L. 1989: Serum procollagen iii peptide in liver cirrhosis relationships to prognosis child grading score and other laboratory parameters. Journal of Hepatology 9(Suppl 1): S226
Lotterer, E.; Wensing, G.; Kuegler, C.; Habib, L.; Norgauer, W.; Hahn, E.G.; Fleig, W.E. 1991: Serum procollagen iii peptide levels are similar in alcoholic and non alcoholic non viral cirrhosis. Hepatology 14(4 Part 2): 186A
Bjorkman, D.J.; Boschert, M.E.; Tolman, K.G.; Clegg, D.; Ward, J.R. 1991: Serum procollagen iii peptide levels in chronic methotrexate therapy for rheumatoid arthritis. Hepatology 14(4 Part 2): 269A
Goddard, C.J.R.; Smith, A.; Halder, T.; Hillier, V.F.; Warnes, T.W. 1994: Serum procollagen peptide assays in primary biliary cirrhosis Synthesis and degradation. Hepatology 20(4 Part 2): 151A
Abdel Rahman, Hosna M.; Shahin, M.; El Sahly, A.M.; Schuppan, R.; Seitz, H.; Risteli, J. 1992: Serum procollagen peptides and collagen type VI in assessing the activity of hepatic fibrosis in schistosomiasis and alcoholic hepatic cirrhosis. Miyai, K, Kanno, T, Ishikawa, E International Congress Series; Progress in clincal biochemistry: 1037-1039
E.D.n M.N.; Schuppan, D.; Risteli, J.; Risteli, L.; Savolainen, E.R.; Seitz, H.K. 1990: Serum procollagen peptides for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Gastroenterology 98(5 Part 2): A616
Kyd, P.A.; Jamil, A.; Fairney, A. 1993: Serum procollagen type I carboxy-terminal extension peptide as an osteoblast marker of bone turnover. Calcified Tissue International 52(Suppl 1): S7
Serejo, F.; Raimundo, M.; Marinho, R.; Velosa, J.; Ramalho, F.; Baptista, A.; Costa, A.; Moura, M.C.D. 1993: Serum procollagen type III peptide A predictive factor of relapse in chronic hepatitis C treated with ALFA-2-b interferon ? Correlation with histological activity. Gastroenterology 104(4 Suppl): A989
Klappacher, G.; Mundigler, G.; Pacher, R.; Giogar, D. 1992: Serum procollagen type iii amino terminal peptide in dilated cardiomyopathy. European Heart Journal 13(ABSTR Suppl): 101
Velosa, J.; Serejo, F.; Saraiva, A.; Marinho, R.; Ramalho, F.; Moura, M.C.D. 1990: Serum procollagen type iii peptide in chronic hepatitis b treated with recombinant interferon alfa 2b. Journal of Hepatology 11(Suppl 1): S173
Serejo, F.; Costa, A.; Marinho, R.; Raimundo, M.; Ramalho, F.; Velosa, J.; Baptista, A.; Moura, M.C. 1991: Serum procollagen type iii peptide p iii np in chronic nanb hepatitis treated with 2b interferon ifn its correlation with histological activity. Journal of Hepatology 13(Suppl 2): S171
Klinger, B.; Laron, Z.; Pertzelan, A.; Rasmussen, L.H.; Jensen, L.T. 1989: Serum procollagen type iii piiinp reflects the short term response to gh treatment in children with css. Hormone Research 31(Suppl 1): 35
Larizza, D.; Spirano, P.; Maghnie, M.; Capodieci, C.; Casati, A.; Baroli, A.; Losi, R. 1989: Serum procollagen type iii propeptide levels in turners syndrome. Bierich, J R , E Cacciari And S Raiti Serono Symposia Publications From Raven Press, Vol 56 Growth Abnormalities; International Symposium, Bologna, Italy, June 22-24, 1988 Xx+476p Raven Press: New York, New York, Usa Illus 347-352
Digenis, G.E.; Zerefos, N.; Christophoraki, M.; Papantoniou, A.; Mavrikakis, M.; Papantoniou, V.; Samuilidi, E.; Moulopoulos, S. 1992: Serum procollagen type-I as a biological parameter of bone metabolism in hemodialysis Preliminary results. Nephrology Dialysis Transplantation 7(7): 757
Vargas, C.A.; Jeffers, L.J.; Civantos, F.; Cheinquer, H.; Albanese, A.; De Medina, M.; Hill, M.; Larue, S.; Parker, T. 1993: Serum procollagen-III-peptide levels in patients with chronic liver disease. Gastroenterology 104(4 Suppl): A1014
Silbergeld, A.; Jensen, L.; Davidovits, M.; Klinger, B.; Eshet, R.; Laron, Z. 1998: Serum procollagens in children with chronic renal failure before and during hGH therapy. Hormone Research (Basel) 50(Suppl 3): 41
Schneider, C.M.; Fort, I.L.; Hayward, R.; Balog, J.M.; Kreider, D.L. 1997: Serum profile of middle-aged males following exercise-induced muscle injury. Medicine and Science in Sports and Exercise 29(5 Suppl): S52
Gawad, Y.; Bonnell, R.; Leitmann, R.; Tsang, M.; Worren, I.; Luxton, G.; Tanser, P.; Stanton, E.; Jackowski, G. 1995: Serum profile of multiple cardiac biochemical markers in patients presenting to the ER with chest pain. Clinical Chemistry 41(S6 Part 2): S166
Fielder, P.J.; Gargosky, S.E.; Vaccarello, M.; Wilson, K.; Cohen, P.; Diamond, F.; Guevara-Aguirre, J.; Rosenbloom, A.L.; Rosenfeld, R.G. 1993: Serum profiles of insulin-like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin-like growth factor i. Acta Paediatrica . Suppl 388: 40
Parissis, J.; Venetsanou, K.; Mentzikof, D.; Ziras, N.; Georgopoulou, M.; Giannakopoulos, N.; Gikopoulos, M.; Kefalas, C.; Karas, S. 1997: Serum profiles of proinflammatory cytokines and their soluble receptors according to the severity of acute myocardial infarction. European Heart Journal 18(ABSTR Suppl ): 632
Parissis, J.; Venetsanou, K.; Mentzikof, D.; Ziras, N.; Gikopoulos, M.; Merkouris, K.; Kefalas, C.; Karas, S. 1998: Serum profiles of soluble cellular adhesion molecules in hypertensive patients with or without significant hyperlipidaemia. European Heart Journal 19(ABST Suppl ): 71
Bustillo, M.; Stern, J.J.; King, D.; Coulam, C.B. 1993: Serum progesterone and estradiol concentrations in the early diagnosis of ectopic pregnancy after in vitro fertilization-embryo transfer. Fertility and Sterility 59(3): 668-670
Ding, K.W.; Han, G.W.; Wei, G.S.; Liu, M.F. 1995: Serum progesterone concentration and its relations to live litter size and backfat thickness in Harbin White and Duroc pigs. Journal of Animal Science 73(Suppl 1): 302
Bojanic, S.; Lake, R.; Place, J.; Jones, L.; Laycock, J.F.; Carter, G.D.; Alaghband-Zadeh, J. 1991: Serum progesterone concentration is raised during early follicular phase in women with polycystic ovaries. Annals of Clinical Biochemistry 28: 105-106
Voss, F.; Stern, J.; Coulam, C. 1991: Serum progesterone determinations in early ectopic gestations. Surgical Forum 42: 493-494
Herrick, C.N.; Glass, B.A.; Taslimi, M.M. 1991: Serum progesterone in ectopic pregnancy. Southern Medical Journal 84(9): 2S33
Sweitzer, R.A.; Holcombe, D.W. 1993: Serum progesterone levels and pregnancy rates in Great Basin porcupines. Journal of Mammalogy 74(3): 769-776
Tsubota, T.; Howell-Skalla, L.; Boone, W.R.; Garshelis, D.L.; Bahr, J.M. 1998: Serum progesterone, oestradiol, luteinizing hormone and prolactin profiles in the female black bear (Ursus americanus). Animal Reproduction Science 53(1-4): 107-118
Sharif, M.; George, E.; Kirwan, J.; Shepstone, L.; Knudson, W.; Thonar, E.J.M.A.; Cushnaghan, J.; Dieppe, P.A. 1994: Serum prognostic markers of osteoarthritis of the knee joint. Arthritis and Rheumatism 37(9 Suppl): S345
Roder, M.E.; Hartling, S.G.; Linde, S.; Welinder, B.; Binder, C. 1991: Serum proinsulin immunoreactivity is heterogeneous in normals and in type 2 diabetes mellitus. Diabetologia 34(Suppl 2): A15
Mykkanen, L.; Kuusisto, J.; Hales, C.N.; Pyorala, K.; Laakso, M.; Haffner, S.M. 1994: Serum proinsulin levels are disproportionally increased in elderly prediabetic subjects. Diabetologia 37(Suppl 1): A74
Schneider, F.A.; Hallford, D.M.; Kridli, R.T.; Graham, D.B. 1995: Serum prolactin and LH and onset of luteal activity in ewe lambs treated with bromoergocryptine during early breeding. Journal of Animal Science 73(Suppl 1): 295
Moneim, N.A.A.del; Fahmy, E.I.; Motawei, M.A.; Bayoumi, D.; Mohsen, S.E.A.del; Moussa, S.M. 1994: Serum prolactin and carcinoembryonic antigen relationship to clinical staging and histopathologic data Indicators of disease progression and response to treatment in cancer breast. Journal of the Medical Research Institute 15(1): 1-8
Martinez, A.; Matias Guiu, J.; Sastre, J.; Martin, R.; Molto, J.M.; Insa, R.; Carbonell, J. 1990: Serum prolactin and convulsive seizures in pediatric patients. Journal of Neurology 237(Suppl 1): S76
Singh, U.K.; Jana, U.K. 1994: Serum prolactin and cortisol in children with some paroxysmal disorders. Indian Journal of Pediatrics 61(1): 57-61
Schneider, F.A.; Hallford, D.M.; Birch, M.W.; Christensen, B.L.; Kridli, R.T.; Graham, D.B. 1994: Serum prolactin and onset of luteal activity in ewe lambs treated with melatonin microspheres and bromoergocryptine. Journal of Animal Science 72(Suppl 2): 115
Gomez Vaquero, C.; Juanola, X.; Navarro, M.A.; Mateo, L.; Ros, S.; Roig Escofet, D. 1996: Serum prolactin and salivary testosterone in young and middle-aged men with ankylosing spondylitis. British Journal of Rheumatology 35(ABSTR Suppl 1): 152
Maina, D.; Katz, L.S. 1995: Serum prolactin and testosterone concentrations are not altered by sexual behavior in mature rams. Journal of Animal Science 73(Suppl 1): 129
Cosson, C.; Myara, I.; Guillemain, R.; Amrein, C.; Dreyfus, G.; Moatti, N. 1989: Serum prolactin as a rejection marker in heart transplantation. Clinical Chemistry 35(3): 492-493
Sheng, Y.F.; Huang, Y.M. 1993: Serum prolactin before and after gynecological operations. Acta Academiae Medicinae Shanghai 20(1): 79
Silbergeld, A.; Klinger, B.; Schwartz, H.; Laron, Z. 1993: Serum prolactin in Laron syndrome Effect of insulin-like growth factor 1. Laron, Z , Parks, J S Pediatric and Adolescent Endocrinology; Lessons from Laron Syndrome (LS) 1966-1992: A model of GH and IGF-1 action and interaction : 261-265
Russell, I.J.; Vipraio, G.A. 1993: Serum prolactin in fibromyalgia syndrome , rheumatoid arthritis osteoarthritis and healthy normal controls. Arthritis and Rheumatism 36(9 Suppl): S222
Legido, A.; Lago, P.; Chung, H.J.; Sperling, M.; Clancy, R.R. 1992: Serum prolactin in newborns with seizures reflects the severity of the underlying encephalopathy. Epilepsia 33(Suppl 3): 113-114
Morales, A.; Bass, N. 1991: Serum prolactin in the diagnosis of neonatal seizures. Epilepsia 32(Suppl 3): 69
Lozoff, B.; Felt, B.T.; Nelson, E.C.; Wolf, A.W.; Meltzer, H.W.; Jimenez, E. 1995: Serum prolactin levels and behavior in infants. Biological Psychiatry 37(1): 4-12
Halko, G.; Urrows, S.; Afflect, G.; Waterman, J. 1995: Serum prolactin levels and disease activity in rheumatoid arthritis. Arthritis and Rheumatism 38(9 Suppl): S289
Weiss, R.D.; Hufford, C.; Mendelson, J.H. 1994: Serum prolactin levels and treatment outcome in cocaine dependence. Biological Psychiatry 35(8): 573-574
Gaufo, G.O.; Husmillo, M.; Diamond, M.C. 1993: Serum prolactin levels in congenitally athymic mice grafted with a thymus and/or pituitary gland. Society for Neuroscience Abstracts 19(1-3): 503
Kuruvilla, A.; Srikrishna, G.; Peedicayil, J.; Kuruvilla, K.; Kanagasabapathy, A.S. 1991: Serum prolactin levels in manic patients. Biological Psychiatry 30(4): 421-423
Nicol, M.; Willis, C.; Yiangou, C.; Shousha, S. 1998: Serum prolactin levels in patients presenting with various operable breast lesions. Journal of Pathology 184(Suppl): 24A
Stolte, I.; Van Den Hoogen, F.; Wijnands, M.; Sweep, F.; Van, D.P.tte, L. 1996: Serum prolactin levels in patients with SLE and SLE-overlap syndrome. Arthritis and Rheumatism 39(9 Suppl): S295
Szulc Kuberska, J.; Stepien, H.; Klimek, A.; Cieslak, D. 1990: Serum prolactin levels in patients with amyotrophic lateral sclerosis after metoclopramide stimulation. Neuroendocrinology 52(Suppl 1): 144
Pozsonyi, T.; Pajor, A.; Cseh, K.; Jakab, L.; Kalabay, L.; Jakab, L. 1995: Serum prolactin levels in systemic lupus erythematosus and rheumatoid arthritis. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 420
Ratnasooriya, W.D.; Fernando, S.B.U.; Manatunga, A.M.V.R. 1993: Serum prolactin levels of Sri Lankan elephants. Medical Science Research 21(6): 259-261
Nishino, S.; Arrigoni, J.; Sharp, L.H.; Shelton, J.D.; Dement, W.C.; Mignot, E. 1992: Serum prolactin response to a D2 antagonist in narcoleptic and control canines. Sleep 15(5): 474-475
Felt, B.; Arjona, N.; Lozoff, B. 1997: Serum prolactin response to stressors in children. Pediatric Research 41(4 Part 2): 14A
Tarçin, O.; Gedik, N.; Karakoyun, B.; Tahan, V.; Sood, G.; Celikel, C.ğd.; Tözün, N. 2008: Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats. Digestive Diseases and Sciences 53(7): 1938-1945
Testa, R.; Bindi, P.; Dagnino, F.; Borzone, S.; Caglieris, S.; Bardellini, E.; Grasso, A.; Celle, G. 1991: Serum prolyl hydroxylase as marker of active fibrogenesis in chronic liver diseases. Journal of Hepatology 13(Suppl 2): S76
Testa, R.; Bindi, P.; Dagnino, F.; Bardellini, E.; Grasso, A.; Celle, G. 1989: Serum prolylhydroxylase in liver cirrhosis reproducibility of a probably non redundant test for liver disease. Journal of Hepatology 9(Suppl 1): S234
Kamp, D.W.; Dunne, M.; Anderson, J.A.; Weitzman, S.A.; Dunn, M.M. 1989: Serum promotes asbestos induced injury to human alveolar epithelial cells. Clinical Research 37(2): 477A
Schulman, S.; Canada, A.; Ginsberg, B.; Glass, P.S.A. 1995: Serum propofol level associated with antiemetic effect. Anesthesia and Analgesia 80(2 Suppl): S419
Melegos, D.N.; Grass, L.; Pierratos, A.; Diamandis, E.P. 1998: Serum prostaglandin D synthase concentration is elevated in humans with renal impairment. Clinical Chemistry 44(6 Part 2): A20
Kadavifci, A.; Simsek, H.; Savas, M.C.; Kirazli, S. 1997: Serum prostaglandin E2 levels in familial Mediterranean fever. European Journal of Clinical Investigation 27(Suppl 1): A19
Braswell, N.T.; FoowlerJackson, E.Jr.; Seaver, L.E.; Pandey, P. 1993: Serum prostate specific antigen after flutamide administration in patients with localized and metastatic prostate cancer and increasing PSA following surgical or medical castration. Journal of Urology 149(4 Suppl): 428A
Catalona, W.J.; Ratliff, T.L.; Yuan, J.J.J. 1990: Serum prostate specific antigen as a first line screening test for prostate cancer. Journal of Urology 143(4 Suppl): 313A
Gillatt, D.; Gingell, C.; Smith, P.J.B. 1990: Serum prostate specific antigen for the assessment of response to hormonal therapy. Journal of Urology 143(4 Suppl): 207A
Wadhwa, N.K.; Solomon, M.; Suh, H.; Sokunbi, D. 1993: Serum prostate specific antigen in end stage renal disease patients. Journal of the American Society of Nephrology 4(3): 394
Black, M.H.; Giai, M.; Yu, H.; Diamandis, E.P. 1998: Serum prostate specific antigen levels are elevated in females with breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 39: 553
Andriole, G.L. 1993: Serum prostate-specific antigen: expanding its role as a measure of treatment response in patients with prostate cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 11(4): 596-597
Fendler, J.P.; Joubert, P.; Devonec, M.; Perrin, P. 1994: Serum prostate-specific antigen after locoregional treatment of adenocarcinoma of the prostate. Bolla, M, Rambeaud, J J, Vincent, F Contributions to Oncology; Local prostatic carcinoma 130-136
Christensson, A.; Abrahamsson, P.A.; Lilja, H. 1994: Serum prostate-specific antigen complexed to alpha-1-antichymotrypsin shows higher diagnostic specificity in prostate cancer. Imai, K, Shimazaki, J, Karr, J P Fundamental approaches to the diagnosis and treatment for prostate cancer and BPH 83-90
Sershon, P.D.; Barry, M.J.; Oesterling, J.E. 1994: Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer. European Urology 25(4): 281-287
Malkowicz, S.B. 1996: Serum prostate-specific antigen elevation in the post-radical prostatectomy patient. Urologic Clinics of North America 23(4): 665-675
Oesterling, J.E.; Jacobsen, S.J.; Chute, C.G.; Guess, H.A.; Girman, C.J.; Panser, L.A.; Lieber, M.M. 1993: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 270(7): 860-864
Romppanen, J.; Keskikuru, R.; Kataja, V.; Eskelinen, M.; Kosma, V.M.; Savolainen, K.; Uusitupa, M.; Mononen, I. 1998: Serum prostate-specific antigen in benign and malignant brest disease. Clinical Chemistry 44(6 Part 2): A40
Pollack, A.; Zagars, G.K. 1993: Serum prostate-specific antigen levels three months after radiotherapy for prostate cancer. Journal of Urology 149(4 Suppl): 395A
Cecco, S.A.; Rehak, N.N. 1994: Serum prostatic acid phosphatase activity and concentration compared. Clinical Chemistry 40(6): 1005
Moul, J.W.; Connelly, R.R.; Perahia, B.; Pinto, A.; Mooneyhan, R.M.; Mcleod, D.G. 1997: Serum prostatic acid phosphatase in the 1990s Biomarker for organ confinement and recurrence after radical prostatectomy?. Journal of Urology 157(4 Suppl): 299
Labrie, F.; Dupont, A.; Suburu, E.R.; Gomez, J.L.; Cusan, L.; Lemay, M.; Koutsilieris, M.; Diamond, P. 1993: Serum prostatic specific antigen is a highly efficient prescreening test for prostate cancer. Journal of Urology 149(4 Suppl): 413A
Brackett, N.L.; Ferrell, S.M.; Aballa, T.C.; Lynne, C.M. 1997: Serum prostatic specific antigen is higher in spinal cord injured men compared to normal men. Society for Neuroscience Abstracts 23(1-2): 1524
Labrie, F.; Dupont, A.; Temblay, M.; Gomez, J.L.; Suburu, E.R.; Thibeault, M.M.; Emond, J.; Cusan, L. 1991: Serum prostatic specific antigen levels and prescreening of prostate cancer. Clinical and Investigative Medicine 14(4 Suppl): A122
Ezzell, J.W.Jr; Abshire, T.G. 1990: Serum protease cleavage of bacillus anthracis protective antigen. Abstracts of the Annual Meeting of the American Society for Microbiology 90: 79
Ghanem, G.; Loir, B.; Sales, F.; Pector, J.C.; Ewalenko, P.; Kerger, J.; Lienard, D.; Lejeune, F.; Deraemaecker, F.; Fruhling, J. 1997: Serum protein S-100 is a useful marker in metastatic melanoma. Melanoma Research 7(Suppl 1): S55
Jolliff, C.; Hergenrader, P.; Bennett, S. 1996: Serum protein analysis comparing agarose gel electrophoresis versus an automated capillary zone electrophoresis system. Clinical Chemistry 42(6 Part 2): S104
Borga, B.; Borga, O. 1996: Serum protein binding NSAIDS. Pharmaceutical Research (New York) 13(9 Suppl): S421
Moshenko, J.L.; Ma, S.; Abbott, F.S. 1996: Serum protein binding and distribution of -2,3-diene VPA to rat brain and liver. Pharmaceutical Research (New York) 13(9 Suppl): S420
Ter Laak, A.M.; Bijloo, G.J.; Fischer, M.J.E.; Donne, O.D.n Kelder, G.M.; Wilting, J.; Timmerman, H. 1996: Serum protein binding of histamine H-1-antagonists A comparative study on the serum protein binding of a sedating mepyramine and a non-sedating H-1-antagonist loratadine. European Journal of Pharmaceutical Sciences 4(5): 307-319
Wad, N.; Bourgeois, B.; Kramer, G. 1997: Serum protein binding of methsuximide and its desmethyl metabolite. Epilepsia 38(Suppl 8): 91
Villa, R.; Prandini, E.; Caloni, F.; Carli, S. 1997: Serum protein binding of some sulphonamides, quinolones and fluoroquinolones in farm and domestic animals. Journal of Veterinary Pharmacology and Therapeutics 20(Suppl 1): 34-35
Evans, R.W.; Crook, M.; Sanakralingham, A.; Norman, J.; Exworthy, T.; Boelaert, J.R. 1994: Serum protein cellulose-acetate electrophoresis in Alzheimers disease. Medical Science Research 22(2): 105-106
Hristev,H.; Penkov,D.; Hallak,A.K.; Kirova,M.; Baykov,B.; Bliznakov,A. 2008: Serum protein changes in rabbits after chronic administration of lead and cadmium. Journal Of Central European Agriculture: 1, 141-145
Teixeira,M.C.A.; Marques,L.C.; Cadioli,F.A.; Fagliari,J.J.; Machado,R.Z.; Silva,P.C. 2008: Serum protein concentrations in Wistar rats experimentally infected with Trypanosoma evansi. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia 60(6): 1447-1453
Schoonbrood, D.F.M.; Out, T.A.; Van, D.G.aaf E.A.; Jansen, H.M. 1991: Serum protein concentrations in noninfected sputum sol phase from patients with copd and asthma. American Review of Respiratory Disease 143(4 Part 2): A48
Santana,A.M.; Fagliari,J.J.; Camargo,C.M.S.; Santana,A.E.; Duarte,J.M.B.; Silva,P.R.L. 2008: Serum protein concentrations of captive brown brocket deer determined by means of agarosis and sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia 60(6): 1560-1563
Kahn, S.N. 1992: Serum protein electrophoresis is it useful?. Journal of Clinical Immunoassay 15(3): 162-166
Pires,T.T.; Rostan,G.; Bittencourt,T.C.C.de; Almeida,M.A.O.de; Guimaraes,J.E. 2008: Serum protein electrophoresis of free-ranging and captive loggerhead sea turtles , from north coast of Bahia, Brazil. Brazilian Journal Of Veterinary Research And Animal Science: Supplement, 121-126. Ef
Qi, L.; Cazares, L.; Johnson, C.; de Alarcon, P.; Kupfer, G.M.; Semmes, O.John. 2008: Serum protein expression profiling in pediatric Hodgkin lymphoma: a report from the Children's Oncology Group. Pediatric Blood and Cancer 51(2): 216-221
Richard, J.L.; Ducimetiere, P.; Warnet, J.M.; Claude, J.R. 1990: Serum protein fractions and cardiovascular mortality in the paris prospective study i. European Heart Journal 11(ABSTR Suppl): 174
Devo, D.; Navid, F.; Cefalu, W.T. 1989: Serum protein glycation in type i diabetic patients does not effect routine hematologic profile. Clinical Research 37(1): 118A
Ogbonna, C.; Onwuamaeze, I. 1995: Serum protein in pregnant Nigerian women. Clinical Chemistry 41(S6 Part 2): S151
Andorn, A.C.; Pappolla, M.A. 1989: Serum protein interactions with neurotransmitter receptors: implications for Alzheimer's disease. Progress in Clinical and Biological Research 317: 695-701
Munoz, D.G.; Erkinjuntti, T.; Gaytan-Garcia, S.; Hachinski, V. 1997: Serum protein leakage in Alzheimer's disease revisited. Annals of the new York Academy of Sciences 826: 173-189
Medina-Cruz,M.; Cruz,C.; Montaldo,H.H. 2008: Serum protein levels in Holstein calves fed pasteurized-frozen-thawed or unpasteurized first-milk colostrum. Bovine Practitioner: 2, 201-205
Dhaliwal, G.S.; Sharma, R.D.; Biswas, R.K. 1990: Serum protein levels in buffaloes following induction of estrus pgf 2 alpha using two routes. Indian Journal of Animal Sciences 60(3): 327-328
Matsumoto, T.; Itou, M. 1991: Serum protein levels in quintuplet pregnancy and delivery. Mie Medical Journal 41(1): 77-81
Ellis, A.K. 1991: Serum protein measurements and the diagnosis of acute myocardial infarction. Circulation 83(3): 1107-1109
Fedrizzi, S.M.G.; Gomes Marcondes, M.C.C. 1998: Serum protein of young pregnant rats bearing walker 256 carcinoma. Biology of Reproduction 58(Suppl 1): 202
Saleh, M.A.; Zeid, M.A.; Blancato, J.N. 1995: Serum protein profile A possible biomarker for exposure to insecticides. Abstracts of Papers American Chemical Society 209(1-2): AGRO 116
Alagaratnam, S.; Mertens, B.J.A.; Dalebout, J.C.; Deelder, A.é M.; van Ommen, G.-J.B.; den Dunnen, J.T.; 't Hoen, P.A.C. 2008: Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 8(8): 1552-1563
Barka, N.; Reagan, K.J.; Agopian, M. 1995: Serum protein quantitation using IFCC standard Comparison of Behring and Beckman nephelometry systems. Clinical Chemistry 41(S6 Part 2): S183
Brett, F.L.; Cohn, D. 1997: Serum protein, allozyme and blood group markers in the Awash hybrid zone. American Journal of Physical Anthropology 1997(Suppl 24): 81
Johnson, M.; Gong, H.; Freddo, T.; Kamm, R. 1992: Serum proteins and aqueous outflow resistance. Experimental Eye Research 55(Suppl 1): S67
Hammerle, A.F.; Pöschl, G.; Kirnbauer, R.; Trautinger, F.; Micksche, M.; Mayrhofer, O. 1989: Serum proteins and cytokines for prediction of sepsis?. Progress in Clinical and Biological Research 308: 715-718
Mathias, M.D.L.z; Mira, A. 1992: Serum proteins and hematological values in the Fallow deer. Mammalia 56(3): 485-488
Kalaria, R.N.; Kroon, S.N.; Perry, G. 1993: Serum proteins and the blood-brain barrier in the pathogenesis of Alzheimers disease. Nicolini, M , Zatta, P F , Corain, B Advances in the Biosciences; Alzheimer's disease and related disorders : 281-282
Palmer, B.D.; Selcer, K.W. 1994: Serum proteins as biomarkers for xenobiotic estrogens in wildlife. Biology of Reproduction 50(Suppl 1): 100
Solar, I.; Muller-Eberhard, U.; Shaklai, N. 1989: Serum proteins as mediators of hemin efflux from red cell membranes: specificity of hemopexin. Febs Letters 256(1-2): 225-229
Paria, B.C.; RosenkransC.F.Jr.; Tarn, C.Y.; Johnson, Z.B.; Brown, A.H.Jr 1994: Serum proteins as predictors of carcass characteristics of steers. Journal of Dairy Science 77(Suppl 1): 315
Tarn, C.Y.; RosenkransC.F.Jr.; Heird, C.E.; Johnson, Z.B.; BrownA.H.Jr.; Lewis, P.K. 1994: Serum proteins as related to growth rate and carcass traits of steers. Journal of Animal Science 72(Suppl 2): 26
Witola, W.H.; Lovelace, C.E.A. 1997: Serum proteins changes in indigenous Zambian goats with trypanosomosis. FASEB Journal 11(9): A1257
Van Den Bogaerde, J.; Clark, B.T.; Gewertz, B.L. 1995: Serum proteins facilitate neutrophil induction of endothelial ELAM-1. FASEB Journal 9(3): A35
Simbeve, A.G.A. 1989: Serum proteins immunoglobulin and complement c 3 and c 4 levels in downs syndrome in kuwait sample. Clinical Chemistry 35(6): 1081
Berttni, F. 1961: Serum proteins in allopatric and sympatric populations of Leptodactylus ocellatus and L chaquensis. Copeia: 336-340
Kalaria, R.N.; Kroon, S.N. 1991: Serum proteins in neurofibrillary pathology of alzheimers disease ad antithrombin iii like immunoreactivity. Society for Neuroscience Abstracts 17(1-2): 725
Holloway, H.L.Jr; Ottinger, C.A. 1990: Serum proteins in paddlefish and egg infections with polypodium hydriforme. American Zoologist 30(4): 13A
Muller, E.; Goldmann, D.; Pier, G.B. 1990: Serum proteins inhibit the adherence of coagulase negative staphylococci cns to biomaterials. Abstracts of the Annual Meeting of the American Society for Microbiology 90: 111
Liao, Q.; Zhao, L.; Chen, X.; Deng, Y.; Ding, Y. 2008: Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma. Clinical and Experimental Metastasis 25(4): 465-476
Cecconi, D.; Tessari, M.; Willé, D.R.; Zoli, M.; Domenici, E.; Righetti, P.G.; Carboni, L. 2008: Serum proteomic analysis during nicotine self-administration, extinction and relapse in rats. Electrophoresis 29(7): 1525-1533
Hui, L.; Diandong, H.; Baoxia, Z.; Da, W.; Hong, Y.; Xiaoyi, W. 2007: Serum proteomic profiling associated with immune system impaired by stress using ProteinChip technology. Neuroimmunomodulation 14(6): 326-330
Shih, W.J.; Wierzbinski, B.; Mitchell, B.; Collins, J.; Trepashko, D.W.; Delworth, M.; Ryo, U.Y. 1990: Serum psa and pap level measurement in the prediction of the patients with prostate adenocarcinoma from the patients with prostate nodular hyperplasia. Journal of Nuclear Medicine 31(5 Suppl): 791
Andriole, G.L.; Coplen, D.E.; Telle, W.B.; Catalona, W.J. 1992: Serum psa index psai as a staging tool for patients with otherwise clinically localized prostate cancer cap. Journal of Urology 147(4 Suppl): 292A
Levine, A.C.; Kirschenbaum, A.; Kaplan, P.; Droller, M.A.; Gabrilove, J.L. 1989: Serum psa levels in 12 men treated with a long acting gnrh analogue for benign prostatic hypertrophy. Clinical Research 37(2): 361A
Miller, J.I.; Ahmann, F.R.; Drach, G.W.; Bottaccini, M.R. 1991: Serum psa levels predict duration of remission and survival post hormone therapy of metastatic prostate cancer. Journal of Urology 145(4 Suppl): 384A
Van Lith, H.A.; Meijer, G.W.; Haller, M.; Beynen, A.C. 1991: Serum pseudocholinesterase activity in rabbits fed simvastatin. Biochemical Pharmacology 41(3): 460-461
Annapurna, V.; Kutty, K.M.; Davis, A.J.; Curtis, J. 1989: Serum pseudocholinesterase in human and experimental diabetes. Clinical Biochemistry 22(5): 410
Grzeszczak, W.; Szczechowska, E.; Gumprecht, J.; Snit, M.; Moczulski, D.; Kaminski, M. 1995: Serum putrescine, spermine and spermidine concentrations in uremic patients. Nephrology Dialysis Transplantation 10(6): 983
Kung, V.T.; Gomez, B.Jr 1998: Serum pyridinium crosslinks assay. Official Gazette of the United States Patent and Trademark Office Patents 1209(1): 449
Urena, Pablo; Ferreira, Anibl; Kung, Viola; Simon, Pierre; Ang, Kim; Souberbielle, Jean Claude; Segre, Gino; Drueke, Tilman; De Vernejoul, Marie Christine 1994: Serum pyridinoline and bone metabolism in hemodialysis patients. Journal of the American Society of Nephrology 5(3): 858
Tamai, O.; Nishida, H.; Kohno, K.; Ohara, A.; Matsuoka, H.; Majima, K.; Hori, Y.; Imaizumi, T.; Nomura, G. 1994: Serum pyridinoline and deoxy-pyridinoline as valuable markers of bone turnover in patients with renal osteodystrophy. Journal of the American Society of Nephrology 5(3): 857
Azuma, Y.; Mimura, H.; Ohta, T.; Komoriya, K. 1998: Serum pyridinoline and deoxypyridinoline are useful markers for evaluating destruction of articular cartilage and bone in type II collagen-induced arthritis in rats. Japanese Journal of Pharmacology 79(Suppl 1): 102P
Kinugasa, E.; Kohjiro, S.; Watanabe, S.; Nemoto, T.; Koiwa, F.; Sugenoya, Y.; Akizawa, T.; Ideura, T. 1995: Serum pyridinoline derivatives as a new bone metabolic marker in hemodialysis patients. Nephrology Dialysis Transplantation 10(6): 933
Wu, K.; Selhub, J.; Hoffman, S.C.; Comstock, G.W.; Helzlsouer, K.J. 1996: Serum pyridoxal-5-pi-phosphate , B12 and folate and subsequent breast cancer risk. American Journal of Epidemiology 143(11 Suppl): S87
Nagase, H.; Bray, G.A.; York, D.A. 1993: Serum pyruvate and feeding behavior in rat strains that are sensitive or resistant to dietary obesity. Clinical Research 41(4): 757A
Mihm, S.; Monazahian, M.; Grethe, S.; Fechner, C.; Ramadori, G.; Thomssen, R. 1998: Serum ratio of gamma-GT/ALT activity rather than ISDR variability is predictive for virological responsiveness to IFN-alpha therapy in patients infected by HCV genotypes 1A, 1B, and 3A. Journal of Hepatology 28(Suppl 1): 119
Moses, B.H.; South, S.F.; Ubbelohde, M. 1991: Serum reactive plasma nonreactive autoanti kel4 kp b. Transfusion 31(8 Suppl): 26S
Lamarque, D.; Gilbert, T.; Deforges, L.; Roudot Thoraval, F.; Ferrero, R.; Labigne, A.; Delchier, J.C. 1996: Serum reactivity to H pylori antigens assessed by Western Blot in patients with non ulcer dyspepsia, gastric or duodenal ulcer and malt gastric lymphoma. Gut 39(Suppl 2): A119-A120
Vandenborre, C.; Cadranel, S.; Butzler, J.P.; Glupczynski, Y. 1995: Serum reactivity to Helicobacter pylori antigens assessed by helico blot 20 in H pylori-positive children from different ethnic groups. Gut 37(Suppl 1): A79
Mason, A.; Xu, L.; Guo, L.; Munoz, S.; Cao, Y.; Garry, R. 1997: Serum reactivity to retroviral proteins in patients with primary biliary cirrhosis. Gastroenterology 112(4 Suppl): A1328
Bodger, K.; Levy, L.; Clements, D.G.; Morgan, A.G.; Heatley, R.V. 1997: Serum reactivity to specific H pylori antigens and pepsinogen I levels in DU patients. Gastroenterology 112(4 Suppl): A74
Pizzocolo, G.; Rodella, A.; Gussago, A.; Galli, C. 1992: Serum reactivity to structural and non-structural HCV recombinant antigens in acute and chronic infection by a semiautomated immunoassay. Journal of Hepatology 17(Suppl 1): S30
Guadagnino, V.; Sangiuolo, A.; D'alessio, G.; De Vita, G.; Forgione, L.; Salomone Megna, A.; Pedicini, R.; Goglia, G.; Moccia, F.; Maio, G. 1994: Serum receptor interleukina-2-soluble in patients with CAH HCV related and IFN treated Preliminary datas. Giornale di Malattie Infettive e Parassitarie 46(11): 992-993
Vogelsang, P.J.; Marchese, W.; Kost, G.J. 1990: Serum reference intervals for the developing rabbit and perfusate chemistry for age appropriate isolated heart models. Clinical Chemistry 36(6): 1174
Watson, A.J.M.; Donowitz, M.; Montrose, M.H. 1991: Serum regulates sodium proton exchange in caco 2 cells by actin dependent membrane recycling of the exchanger. Gastroenterology 100(5 Part 2): A709
Roeder, R.A.; Garber, M.J. 1989: Serum regulation of protein turnover in myotubes from double muscled bovine fetuses. FASEB Journal 3(4): A939
Arthur, I.D.; Adams, S.; Anthony, F.W.; Thomas, E.J. 1994: Serum relaxin concentrations in pregnant and non-pregnant patients after IVF, hormone supported and natural frozen embryo transfer treatment. Journal of Reproduction and Fertility Abstract Series 1994(13): 30
Mathias, J.R.; Clench, M.H.; Roberts, P.H.; Reeves Darby, V.G. 1993: Serum relaxin levels detected in women with functional bowel disease and reduced by leuprolide acetate therapy. Gastroenterology 104(4 Suppl): A549
Youmbissi, T.J.; Tedong, F.; Tapster, S.; Blackett Ngu, K.; Gonsu, F.J.; Mbock, M.A. 1990: Serum renin activity and aldosterone level in normotensive and hypertensive cameroonians analysis in two hundred and twenty seven subjects. Semaine des Hopitaux 66(15): 789-792
Reinhardt, T.; Zimmerhackl, L.B.; Gordjani, N.; Mueller, H.; Brandis, M. 1996: Serum renin levels correlate with intrarenal resistance measured by duplex Doppler ultrasound in mature and premature infants. Nephrology Dialysis Transplantation 11(6): A68
Logan, J.L.; Benson, B. 1989: Serum renotropic factor rf stimulates prostaglandin pg production by primary cultures of rabbit kidney cells. Kidney International 35(1): 295
Dieckmann, C.; Feldman, E.L. 1995: Serum rescues neurons from hyperosmotic-induced programmed cell death. Society for Neuroscience Abstracts 21(1-3): 2018
Peterson E.M.; Hoshiko M.; Markoff B.; Lauermann M.; De La Maza L.M. 1989: Serum resistance in the lymphogranuloma venereum lgv biotype of chlamydia trachomatis. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 34
Register, K.B. 1998: Serum resistance of Bordetella bronchiseptica isolated from swine does not depend upon the brk or bvg loci. Abstracts of the General Meeting of the American Society for Microbiology 98: 67
Rice, P.A.; McQuillen, D.P.; Gulati, S.; Jani, D.B.; Wetzler, L.M.; Blake, M.S.; Gotschlich, E.C. 1994: Serum resistance of Neisseria gonorrhoeae. Does it thwart the inflammatory response and facilitate the transmission of infection?. Annals of the new York Academy of Sciences 730: 7-14
Mohammadzadeh,G.; Zarghami,N.; Mobaseri,M. 2008: Serum resistin concentration in obese diabetic patients any possible relation to insulin resistance indices?. International Journal Of Endocrinology And Metabolism: 4, 183-193
Ebihara, T.; Saffen, D. 1996: Serum response element -mediated induction of zif268 gene in PC12D cells in inhibited by increases in intracellular calcium. Society for Neuroscience Abstracts 22(1-3): 384
Johansen, F.E.; Prywes, R. 1995: Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation. Biochimica et Biophysica Acta 1242(1): 1-10
Schneider, M.D.; Maclellan, W.R.; Lee T C.; Schwartz, R.J.; Parker, T.G. 1992: Serum response factor and f act 1 mapf1 are candidate trans acting factors for basal and growth factor dependent transcription of the skeletal alpha actin gene in cardiac muscle cells. Journal of Molecular and Cellular Cardiology 24(Suppl 1): S40
Spencer, J.; Misra, R. 1996: Serum response factor gene expression. FASEB Journal 10(6): A1518
Wickramasinghe, S.R.; Alvania, R.S.; Ramanan, N.; Wood, J.N.; Mandai, K.; Ginty, D.D. 2008: Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. Neuron 58(4): 532-545
Dalton, S.; Pollock, R.; Treisman, R. 1992: Serum response factor relatives and friends. Journal of Cellular Biochemistry Suppl (16 Part A): 66
N.S.Y.; Liu S H.; Peng B H. 1990: Serum response factor srf is glycosylated in cultured fibroblasts and mouse embryos. Journal of Cellular Biochemistry Suppl (14 Part B): 186
Gilman, M.; Alexandre, C.; Attar, R.; Grueneberg, D.; Lee, G.; Natesan, S.; Ryan, A.; Sadowski, H.; Simon, K. 1993: Serum response factor-homeodomain complexes and the specificity of nuclear signal transduction. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 59
Johnson, E.J.; Krinsky, N.I.; Russell, R.M. 1996: Serum response of all-trans beta-carotene and lycopene in humans after ingestion of individual and combined doses of beta-carotene and lycopene. FASEB Journal 10(3): A239
Smith, J.C.; Makdani, D.; Hegar, A.; Sowell, A.; Gunter, E.; Rao, D. 1993: Serum response of vitamin A and four retinyl esters following a relative dose response test in children of Belize. FASEB Journal 7(3-4): A303
Foerster, E.C.; Koch, P.; Koch, O.; Tiemann, M.; Domschke, W.; Crabtree, J.E. 1995: Serum response to Helicobacter pylori in primary B-cell gastric lymphoma. Gut 37(Suppl 1): A6
Bales, C.; Lyles, K.; Gold, D.; Drezner, M. 1989: Serum response to pharmacologic amounts of fluoride in osteoporosis patients. FASEB Journal 3(4): A1239
Norris, J.M.; Love, D.N. 1995: Serum responses of cats with periodontal/gingival disease to members of the genus Porphyromonas. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 20(Suppl): S314-S316
Schneider, M.D.; Maclellan, W.R.; Lee T C.; Schwartz, R.J.; Parker, T.G. 1992: Serum responsive factor and f act 1 mapf1 are candidate trans acting factors for basal and growth factor dependent transcription of the skeletal alpha actin gene in cardiac muscle cells. Journal of Cellular Biochemistry Suppl (16 Part F): 113
Trumbore, L.S.; Mobarhan, S.; Henderson, C.T.; Bowen, P.E. 1991: Serum retinoid and carotenoid levels of long term care patients receiving formula and whole foods diets. Journal of the American College of Nutrition 10(5): 557
Dorgan, J.F.; Sowell, A.; Potischman, N.; Swanson, C.; Miller, R.; Jr, H.E.S.ephenson 1996: Serum retinol and antioxidant micronutrients and breast cancer risk. Proceedings of the American Association for Cancer Research Annual Meeting 37: 212
Manns, A.; Maloney, E.; Pate, E.; Wiktor, S.; Ziegler, R.; Gray, R.; Blattner, W. 1995: Serum retinol and beta carotene levels among pregnant women with HTLV-I infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(2): 265
Quinlan, K.P.; Hayani, K.C. 1994: Serum retinol and retinol binding protein levels depressed in respiratory syncytial virus infection, no benefit observed with vitamin A supplementation. Pediatric Research 35(4 Part 2): 192A
Wu, H.; Jia, W.; Bao, Y.; Lu, J.; Zhu, J.; Wang, R.; Chen, Y.; Xiang, K. 2008: Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 79(2): 185-190
MaiHongZhen; WangQiuYue; HanLiPing; KangJian 2008: Serum retinol binding protein-4 level in patients with chronic obstructive pulmonary disease and its relationship to nutritional status. Journal Of China Medical University: 6, 767-769
De Fátima Costa Caminha, M.; da Silva Diniz, A.; Falbo, A.R.; de Arruda, I.K.G.; Serva, V.B.; de Albuquerque, L.L.; de Freitas Lola, M.M.; Ebrahim, G.J. 2008: Serum retinol concentrations in hospitalized severe protein-energy malnourished children. Journal of Tropical Pediatrics 54(4): 248-252
See, J.R.; Baseer, A.; Clevenger, B.J. 1991: Serum retinol levels as a method to measure dietary fat absorption. Clinical Research 39(2): 405A
Haas, D.W.; Raffanti, S.; Chytil, F. 1994: Serum retinol levels do not correlate with survival in hospitalized patients with advanced HIV-1 infection. Clinical Research 42(2): 172A
Benner, S.E.; Fritsche, H.A.; Lee, J.S.; Lippman, S.M.; Hong, W.K. 1995: Serum retinol levels following 13-cis-retinoic acid administration in a chemoprevention trial. Proceedings of the American Association for Cancer Research Annual Meeting 36: 588
Lopez, M.; Quevedo, M.; Fornasini, M.; Diaz, L.; Mantilla, G.; Wiener, D.; Carver, J.D. 1996: Serum retinol levels in mothers and infants from different socioeconomic classes in Quito, Ecuador. Pediatric Research 39(4 Part 2): 315A
Gylling, H.K.; Puska, P.; Vartiainen, E.; Miettinen, T.A. 1996: Serum retinol, alpha-tocopherol, carotenes and lipid peroxide production during serum cholesterol lowering by sitostanol ester margarine in a mildly hypercholesterolemic population. Circulation 94(8): I578
Gómez-Ambrosi, J.; Rodríguez, A.; Catalán, V.; Ramírez, B.; Silva, C.; Rotellar, F.; Gil, M.J.; Salvador, J.; Frühbeck, G. 2008: Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clinical Endocrinology 69(2): 208-215
Johnson, L.; Norkus, E.; Abbasi, S.; Cieplinski, J.; Grous, M.; Gerdes, J.; Bhutani, V.; Bowen, F. 1993: Serum retinyl palmitate in less than 1750 g BW infants. Pediatric Research 33(4 Part 2): 305A
Johnson, L.; Norkus, E.; Abbasi, S.; Cieplinski, J.; Dalin, C.; Cassidy, T.; Gerdes, J.; Bhutani, V.; Bowen, F. 1992: Serum retinyl palmitate in premature infants. Journal of the American College of Nutrition 11(5): 636
Bartlett, R.; Mirkin, J.; Tomaszewski, C.; Fuhrman, C. 1997: Serum rhodanese activity in emergency department patients. Journal of Toxicology. Clinical Toxicology 35(5): 508
Alka, B.; Seth, V.; Mukhopadhaya, S.; Semwal, O.P.; Seth, S.D. 1990: Serum rifampin and isoniazid levels in children with tubercular infections. European Journal of Pharmacology 183(6): 2389
Hogan, K.; White, R.; Gudeman, S.; Henderson, F. 1989: Serum s and cerebrospinal fluid csf concentrations of cefotaxime ct and desacetylcefotaxime dact in patients with csf shunt infections. Clinical Pharmacology and Therapeutics 45(2): 163
Perrella, A.; Guerriero, S.; Soscia, E.; Finelli, L.; Perrella, O. 1994: Serum sCD23 and IgE levels in HIV-1 infection What correlation?. Acta Microbiologica et Immunologica Hungarica 41(Suppl ): 53
Hatzistilianou, M.; Agguridaki, C.; Athanassiadou, F.; Catriu, D. 1995: Serum sCD4, sCD14 and sICAM-1 under the effect of rhG-CSF in children with ALL. Anticancer Research 15(5A): 1715
Sanchez Alonso, A.; Munoz, F.J.; Monteseirin, J.; Conde, J. 1997: Serum sICAM-1 in patients with bronchial asthma. Journal of Investigational Allergology and Clinical Immunology 7(5): 426
Chrobak, L.; Podzimek, K.; Pliskova, L.; Kerekes, Z.; P.Zak; Voglova, J.; Spacek, J.; Palicka, V. 1996: Serum sIL-2R a reliable and non-invasive marker of disease activity in patients with HCL. British Journal of Haematology 93(Suppl 2): 111
Howser, D.; Yankowitz, J.; Ely, J.W. 1995: Serum screening Disparity in practice patterns between obstetricians and family physicians. American Journal of Obstetrics and Gynecology 172(1 Part 2): 391
Brandt Rauf, P.W. 1990: Serum screening for oncogene proteins in occupationally exposed workers. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 2): 982
Zolotukhina, T.V.; Chivilev, I.V.; Yudina, E.V. 1996: Serum screening of mothers in prophylaxis of congenital and hereditary diseases. Pediatriya (Moscow) 1996(4): 26-30
Wendling, D.; Didier, J.M.; Seilles, E. 1993: Serum secretory immunoglobulins in ankylosing spondylitis. Arthritis and Rheumatism 36(9 Suppl): S224
Magill, M.K.; Irvine, A.E.; Drake, M.; Lloyd, F.; Ranaghan, L.; Beattie, G.; Desai, Z.R.; Morris, T.C.M. 1997: Serum secretory leukoprotease inhibitor levels in patients receiving peripheral blood stem cell transplants. British Journal of Haematology 97(Suppl 1): 41
Bernton, E.; Hershey, J.; Franson, R.; Engler, R.; Schwartz, L.; Metcalfe, D.; Worobec, A. 1996: Serum secretory phospholipase A2 levels in patients with mastocytosis. Journal of Allergy and Clinical Immunology 97(1 Part 3): 267
Thompson, F.; Ziegler, R.; Patterson, B.; Weinstein, S. 1997: Serum selenium and cervical cancer risk in the United States. American Journal of Epidemiology 145(11 Suppl): S80
Ferandez Banares, F.; Esteve, M.; Navarro, E.; Mingorance, M.D.; Cabre, E.; Gil, A.; Abad, A.; De Ramon, M.; Boix, J. 1994: Serum selenium and plasma fatty acid levels in patients with adenomatous polyps and colon cancer. Gastroenterology 106(4 Suppl): A385
Li, L.; Nyyssonen, K.; Seppanen, K.; Korpela, H.; Salonen, R.; Salonen, J.T.; Dwyer, J.H. 1995: Serum selenium and risk of incident myocardial infarction and total cancer mortality in a cohort of middle-aged Finnish men The Kuopio Ischemic Heart Disease Risk Factor Study. American Journal of Epidemiology 141(11 Suppl): S65
Maciag, A.; Marchaluk Wisniewska, E.; Akesson, B.; Zachara, B.A. 1998: Serum selenium and selenoprotein P level and glutathione peroxidase activity in healthy subjects compared to lung cancer and breast cancer patients. European Journal of Clinical Investigation 28(Suppl 1): A19
Bleys, J.; Navas-Acien, A.; Stranges, S.; Menke, A.; Miller, E.R.; Guallar, E. 2008: Serum selenium and serum lipids in US adults. American Journal of Clinical Nutrition 88(2): 416-423
Molnar, J.; Pusztai, P.; Molnar, P.; Somogyi, A.; Tulassay, Z. 1998: Serum selenium and zinc concentrations of type I diabetics under intensive insulin treatment. Diabetologia 41(Suppl 1): A324
Cocho, J.A.; Bernabeu, F.A.; Louro, M.O.; Tutor, J.C. 1992: Serum selenium concentrations in patients with porphyria cutanea tarda. Annales de Biochimie Clinique du Quebec 31(2): 24-25
Hossny, E.; El Awady, M. 1995: Serum selenium deficiency in asthmatic children. Journal of Allergy and Clinical Immunology 95(1 Part 2): 273
El Gamal, Yehia; Hossny, Elham; El Awady, Mohamed; Fawwaz, Suzan 1993: Serum selenium in childhood rheumatic diseases. Journal of Allergy and Clinical Immunology 91(1 Part 2): 229
Palmo, Augusta; Gavassa, L.; Protta, F.; Massarenti, P.; Da Pont, C.; Belliardo, F.; Branciforte, L.; Pagni, R. 1994: Serum selenium in total enteral nutrition A randomized study of two dosages of supplementation with se-methionine. Rivista Italiana di Nutrizione Parenterale ed Enterale 12(2): 68-76
Pourmand, G.; Salem, S.; Moradi, K.; Nikoobakht, M.Reza.; Tajik, P.; Mehrsai, A. 2008: Serum selenium level and prostate cancer: a case-control study. Nutrition and Cancer 60(2): 171-176
Brock, K.E.; Gridley, G.; Morris, J.S.; Willett, W.C. 1991: Serum selenium level in relation to in situ cervical cancer in Australia. Journal of the National Cancer Institute 83(4): 292-293
Schaffer-Kronberger, E.; Eber, B.; Wawschinek, O.; Dusleag, J.; Friehs, I.; Gogg, R.; Petek, W.; Klein, W. 1990: Serum selenium levels in distinct manifestations of coronary artery disease. Acta Medica Austriaca 17(1): 22-24
Jiang X R.; Lin H X. 1990: Serum selenium levels in hematological cancer and myelodysplastic syndrome patients. Anticancer Research 10(5 Part B): 1489
Constans, J.; Pellegrin, J.L.; Sergeant, C.; Simonoff, M.; Pellegrin, I.; Fleury, H.; Leng, B.; Conri, C. 1995: Serum selenium predicts outcome in HIV infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 10(3): 392
Costa, R.; Gordon, W.; Jennison, T.; Ash, K.O.; Van Lente, F. 1995: Serum selenium quantitation by ICP/MS using isotope analysis. Clinical Chemistry 41(S6 Part 2): S145
Crespo, A.M.V.egas; Pavao, M.L.; Santos, M.C.; Santos, V.; Neve, J. 1997: Serum selenium, copper and zinc concentrations in inhabitants of S Miguel Island. FASEB Journal 11(9): A1265
Fernandez, R.C.; Weiss, A.A. 1993: Serum sensitivity associated with a Vir-regulated Tn5 lac mutant of Bordetella pertussis. Abstracts of the General Meeting of the American Society for Microbiology 93: 47
Tsukagoshi, Y.; Yamamoto, T. 1997: Serum separating device and apparatus for serum separation. Official Gazette of the United States Patent and Trademark Office Patents 1198(4): 2462-2463
Legario, R.; Nakamura, T.; Shibata, T. 1995: Serum separation sealant. Official Gazette of the United States Patent and Trademark Office Patents 1177(1): 321
Fontes Ribeiro, C.A.; Cotrim, M.D.; Morgadinho, M.T.; Macedo, T.R.A.; Ramos, I.D.; Maduro, A. 1990: Serum serotonin before and after effective drug prevention of migraine attacks. European Journal of Pharmacology 183(5): 1918
Russell, I.J.; Vipraio, G.A.; Lopez, Y.G. 1993: Serum serotonin in fibromyalgia syndrome rheumatoid arthritis osteoarthritis and healthy normal controls. Arthritis and Rheumatism 36(9 Suppl): S222
Fekete, M.; Laszo, A. 1995: Serum serotonin level in infantile autistic children. Clinical Chemistry 41(S6 Part 2): S97
Mikheeva, I.G.; Ryukert, E.N.; Brusov, O.S.; Faktor, M.I.; Vereshagina, T.G.; Kurasova, O.B.; Rudnitskaya, S.Y. 2008: Serum serotonin level in neonates with hypoxic ischemic CNS lesion. Pediatriya 87(1): 40-44
László, A.; Horváth, E.; Eck, E.; Fekete, M. 1994: Serum serotonin, lactate and pyruvate levels in infantile autistic children. Clinica Chimica Acta; International Journal of Clinical Chemistry 229(1-2): 205-207
Apter, D.; Vihko, R. 1990: Serum sex hormone binding globulin and sex steroids in relation to pubertal and postpubertal development of the menstrual cycle. Frisch, R E (Ed ) Progress in Reproductive Biology And Medicine, Vol 14 Adipose Tissue And Reproduction X+142p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 58-69
Garibaldi, L.R.; AcetoT.Jr.; Weber, C.; Clifton, D. 1993: Serum sex hormone binding globulin concentrations are not affected by the estrogen milieu in female central precocious puberty. Pediatric Research 33(5 Suppl): S83
Etherington, J.; Arden, N.; Broad, I.; Buchanan, N.; Spector, T.D.; Hughes, G.R.V. 1996: Serum sex hormones in pregnancy Comparison between lupus, rheumatoid and control patients. British Journal of Rheumatology 35(ABSTR Suppl 1): 35
Ansari, M.Abdul.Jalil.; Begum, D.; Islam, F. 2008: Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia. Annals of Saudi Medicine 28(3): 174-178
Goodyear, M.D.; Browman, G.P.; Russel, R.; Plant, S.; Mcbride, J. 1989: Serum sf and rbc rf folates in patients with advanced head and neck cancer fnc receiving chemotherapy ct with mtx plus minus 5 fu and leucovorin lv. Proceedings of the American Association for Cancer Research Annual Meeting 30: 276
Zhou, Z.H.; Zhang, J.C.; Tucker, J.K.; Ma, H. 1997: Serum sialic acid and acute phase proteins are elevated in NIDDM patients in an Asian population. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 121A
Masuda, H.; Wakabayashi, R.; Wakabayashi, I. 1998: Serum sialic acid and ankle versus brachial arterial-pressure ratio in NIDDM. Scandinavian Journal of Clinical and Laboratory Investigation 58(5): 433-439
Stringou, E.; Chondros, K.; Kakari, S. 1990: Serum sialic acid and carcinoembryonic antigen levels in cancer patients undergoing radiotherapy. Anticancer Research 10(5 Part B): 1441
Assaad Khalil, S.; Lachine, N.; Elewa, S.; Ottian, S.; Seif, M.A.ou 1993: Serum sialic acid and circulating immune complexes in patients with Behcets disease. Wechsler, B , Godeau, P International Congress Series; Behcet's disease 65-68
Zahran, Mahmoud A.; Elewa, Samia M.; Ottian, Soraya A.; El Bardauil, Mona M. 1993: Serum sialic acid and glycosaminoglycans levels in patients with ankylosing spondylitis a possible aid for diagnosis. Journal of the Medical Research Institute 14(2): 169-188
Lindberg, G.; Iso, H.; Rastam, L.; Lundblad, A.; Folsom, A.R. 1995: Serum sialic acid and its correlates in Japanese and US population samples. Circulation 92(8): I219
Lindberg, G.; Råstam, L.; Gullberg, B.; Eklund, G.A.; Törnberg, S. 1991: Serum sialic acid concentration and smoking: a population based study. Bmj 303(6813): 1306-1307
Salomone, O.A.; Crook, J.R.; Hossein-Nia, M.; Holt, D.; Kaski, J.C. 1998: Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris. American Heart Journal 136(4 Pt 1): 620-623
Crook, M.; Tutt, P. 1993: Serum sialic acid in patients with hypertriglyceridaemia showing the Fredericksons 11B phenotype. Clinical Science 84(3): 27P
Ivanov, D.; Gavazova, E.; Antonova, M.; Stankova, S.; Nikolova, P.; Ivanov, S. 1996: Serum sialic acid levels and sialyltransferase activity in cancer. Dokladi na B"lgarskata Akademiya na Naukite 49(7-8): 121-122
Iraklianou, S.; Kamaratos, S.; Laskaris, I.; Irakliotou, S.; Damianaki, D.; Melidonis, A. 1997: Serum sialic acid levels in NIDDM patients with and without diabetic nephropathy Is it a risk factor?. Diabetologia 40(Suppl 1): A522
Erbil, M.K.; Ozata, M.; Cakir, E.; Kenar, L. 1996: Serum sialic acid levels in untreated male hypogonadism. Clinical Chemistry 42(6 Part 2): S229
Mather, H.M.; Roberts, G.A.; Kehely, A.M.; Pasapula, C.; Chusney, G.D.; Pickup, J.C. 1996: Serum sialic acid, a new cardiovascular risk factor, is higher in NIDDM women than men. Diabetologia 39(Suppl 1): A275
Auersvald, L.A.; Perez, R.V.; Lorber, M.I.; Sturges, M.; Friedman, A.L.; Bia, M.J.; Orias, M.; Wilson, J.; Azhderian, E.; Gruber, J. 1995: Serum sialic acid, a risk factor for cardiovascular disease, improves following pancreas transplantation. Transplantation Proceedings 27(6): 3037
Druce, M.; Mahdi, A.; Girgis, S.; Dornhorst, A. 1996: Serum sialic acid, dyslipidaemia and albuminuria in NIDDM. Journal of Endocrinology 151(Suppl ): P21
Rothe E M.; Gross H J.; Raedsch, R.; Krause, J.M.; Brossmer, R.; Kommerell, B. 1992: Serum sialyltransferase activity in different stages of primary biliary cirrhosis. European Journal of Clinical Investigation 22(4 Part 2): A17
Rothe E M.; Gross H J.; Raedsch, R.; Krause, J.M.; Brossmer, R.; Kommerell, B. 1991: Serum sialyltransferase activity in primary biliary cirrhosis. Hepatology 14(4 Part 2): 196A
Lacavalerie, B.; Pouteil Noble, C.; Colon, S.; Aberici, G.; Touraine, J.L. 1992: Serum sickness after rabbit antithymocyte globulin therapy in renal transplantation Incidence, risk factors and histological study. Touraine, J L , Traeger, J , Betuel, H , Dubernard, J M , Revillard, J P , Dupuy, C Transplantation and Clinical Immunology; Evaluation and monitoring in transplantation : 310
George, S.W.; Blankenship, J.C.; Torretti, D. 1992: Serum sickness after streptokinase thrombolysis. Arthritis and Rheumatism 35(9 Suppl): S165
Wong, A.G.; Waserman, S.; Evans, S.; Dolovich, J. 1993: Serum sickness following treatment with anti-thymocyte globulin IgE antibody to rabbit immunoglobulin preparation. Journal of Allergy and Clinical Immunology 91(1 Part 2): 363
Polly, S.M.; Engler, R.J.M.; Birx, D.; Hershey, J.; Carpenter, G. 1991: Serum sickness reaction to natural yellow jacket yj stings associated with significant elevations in yj specific igg1. Journal of Allergy and Clinical Immunology 87(1 Part 2): 240
Guharoy, S.R. 1994: Serum sickness secondary to ciprofloxacin use. Veterinary and Human Toxicology 36(6): 540-541
Yoon, J.M. 1993: Serum sickness-like reactions from neupogen. Blood 82(10 Suppl 1): 507A
Fahal, I.H.; Yaqoob, M.; Rustom, R.; Khalil, A.A.; Roberts, N.B.; Bell, G.M.; Ahmad, R. 1993: Serum silicon profile in patients on CAPD and haemodialysis treatment. Nephrology Dialysis Transplantation 8(9): 1021-1022
Mader, R.; Nicol, P.D.; Sehgal, V.J.; Turley, J.J.; Keystone, E.C. 1992: Serum skeletal myosin light chain levels in the diagnosis and treatment response in inflammatory myopathies. Arthritis and Rheumatism 35(9 Suppl): S89
Roiz, M.C.; Allende, M.T.; Vizoso, F.; Ruibal, A. 1990: Serum slx in non tumor pathology preliminary experience. Revista Clinica Espanola 187(9): 482
Payne, T.A.; Kothary, S.; Varma, N.K.; Nasreddine, W.; Drury, I.; Carney, P.; Beydoun, A. 1997: Serum sodium and thyroid function after replacement of carbamazepine with oxcarbazepine. Epilepsia 38(Suppl 8): 94
Isley, W.L. 1990: Serum sodium concentration abnormalities. Critical Care Nursing Quarterly 13(3): 82-88
Mallie, J.P.; Laroche, F.; Bocquet, G.; Perrier, J.F.; Voltz, C. 1994: Serum sodium concentration variations and electrolyte-free water excretion The serum potassium concentration should be included in the calculation. Journal of the American Society of Nephrology 5(3): 370
Anderson, R.; Katoulis, E.; Hold, A.; Davis, J.R.E.; Laing, I. 1995: Serum sodium is related to insulin dynamics in patients with polycystic ovary syndrome. Journal of Endocrinology 144(Suppl ): P324
Shen, Z.Y.; Gao, H.K. 1996: Serum sodium potassium concentration disturbances feature and with clinical correlated in elderly stroke patients during acute phase. Journal of Neurochemistry 67(Suppl ): S25
Branham, M.L.; Karlix, J.; Tebbett, I.R. 1996: Serum solubilized IL-2 receptor Clinical implications and therapeutic alternatives. Pharmaceutical Research (New York) 13(9 Suppl): S99
Nakazawa, R.; Kaneko, M.; Hoshi, H.; Kim, T.; Nakamura, M.; Azuma, N.; Suzuki, M. 1996: Serum soluble CD14 levels and ultrafiltered dialysate in hemodialysis patients. Nephron 73(3): 493-494
Sarfati, M.; Biron, G.; Leleux, A.; Jacquy, C.; Paesmans, M.; Stryckmans, P.; Fonteyn, C.; Armant, M.; Delespesse, G.; Bron, D. 1993: Serum soluble CD23 is a prognostic marker in chronic lymphocytic leukemia. Journal of Immunology 150(8 Part 2): 99A
Bron, D.; Beral, H.M.; Bernier, M.; Biron, G.; Leleux, A.; Jacquy, C.; Paesmans, M.; Stryckmans, P.; Fonteyn, C. 1993: Serum soluble CD23 is a prognostic marker in chronic lymphocytic leukemia and stage IV lymphocytic lymphoma. Nouvelle Revue Francaise d'Hematologie 35(3): 328
Monafo, V.; De Amici, M.; Avanzini, M.A.; Baua, P.; Calcante, S. 1996: Serum soluble CD23 levels in IgA deficiency. Allergy 51(Suppl 31): 108
D.A.ici, M.; Monafo, V.; Todarello, C.; Castoldi, E.; Ciardelli, L.; Alesina, R. 1996: Serum soluble CD23 levels in patients with allergic respiratory disorders. Allergy 51(Suppl 31): 108
Ohtomo, Y.; Fukuda, Y.; Furukawa, S.; Yabuta, K. 1992: Serum soluble CD4 and CD8 levels in patients with nephrotic syndrome. Pediatric Nephrology 6(5): C130
Ohyasiki, K.; Ohyashiki, J.H.; Nasu, H.; Hibi, N.; Hara, A.; Kubono, K.; Ando, K.; Iwama, H.; Hayashi, S.; Yahata, N.; Toyama, K. 1997: Serum soluble CD44 levels in leukemia and myelodysplastic syndromes for monitoring disease condition. Blood 90(10 Suppl 1 Pt 1): 69A
Ferdeghini, M.; Gadducci, A.; Annicchiarico, C.; Fanucchi, A.; Prontera, C.; Genazzani, A.R.; Bianchi, R. 1997: Serum soluble CD44 standard , CD44 splice variant v5 , and CD44 splice variant v6 in ovarian cancer patients. Tumor Biology 18(Suppl 2): 68
Balázs, C.; Bokk, A.; Farid, N.R. 1994: Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease. Thyroid: Official Journal of the American Thyroid Association 4(1): 27-30
Setsuta, K.; Ohtsuka, T.; Ogawa, T.; Seimya, K.; Seino, Y. 1998: Serum soluble Fas antigen and cardiac troponin T in patients with chronic heart failure. Circulation 98(17): I24
Hasegawa, D.; Kojima, S.; Tatsumi, E.; Kosaka, Y.; Nakamura, H.; Sako, M.; Osugi, Y.; Nagata, S.; Sano, K. 1997: Serum soluble Fas ligand concentrations are elevated in hemophagocytic syndrome and Diamond-Blackfan anemia but not in severe aplastic anemia patients. Blood 90(10 Suppl 1 Pt 2): 15B
Yang, C.W.; Kim, T.K.; Kim, Y.S.; Koo, W.S.; Han, H.; Choi, E.J.; Chang, Y.S.; Bang, B.K. 1995: Serum soluble HLA class I Antigen levels in hemodialysis patients. Blood Purification 13(Suppl 1): 55
Trojano, M.; Avolio, C.; Ruggieri, M.; Liuzzi, M.G.; Defazio, G.; Santacroce, M.; Riccio, P.; Livrea, P. 1998: Serum soluble ICAM-1 and gelatinase B novel markers of clinical efficacy of the RIFN-beta-1b in relapsing-remitting multiple sclerosis. Journal of Neuroimmunology 90(1): 99
Tsubaki, K.; Urase, F.; Ashida, T.; Ishikawa, H.; Hazu, S.; Horiuchi, A. 1995: Serum soluble IL-2 receptor levels of patients with allogeneic bone marrow transplantation. Experimental Hematology 23(8): 867
Ishiga, K.; Omura, H.; Tajima, F.; Kwatani, T.; Kawasaki, H. 1998: Serum soluble c-kit levels during peripheral blood stem cell harvesting. Experimental Hematology 26(8): 713
Furumoto, H.; Sakano, T.; Tanabe, A.; Hara, M.; Ida, N. 1990: Serum soluble CD8 antigen level is not elevated in mucocutaneous lymph node syndrome (Kawasaki disease) in spite of an increase in serum soluble interleukin 2 receptors. European Journal of Pediatrics 149(6): 448-449
Nishanian, P.; Hofmann, B.; Liao, D.; Detels, R.; Fahey, J.J. 1990: Serum soluble cd8 molecule is a marker of immune activation and hiv pathogenesis. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract 1090
Rubin, L.A.; Laxer, R.M.; Nelson, D.L.; Silverman, E.A. 1990: Serum soluble il 2 receptor levels correlate with clinical type and disease activity in juvenile rheumatoid arthritis. Clinical Research 38(2): 580A
Avsar, E.; Tozun, N.; Kalayci, C.; Kiziltas, S.; Kaymakoglu, S.; Cakaloglu, Y.; Okten, A.; Ozgun, S. 1994: Serum soluble intercellular adhesion molecule-1 levels in patients with chronic hepatitis-B in relation to IFN treatment. Journal of Hepatology 21(Suppl 1): S138
Okamoto, H.; Matsuyoshi, N.; Kawai, S. 1989: Serum soluble interleukin 2 receptor levels in patients with inflammatory skin diseases. Clinical Research 37(2): 664A
Lai, C.K.W.; Chan, H.S.; Leung, J.; Lai, K.N. 1991: Serum soluble interleukin 2 receptor sil 2r concentration does not rise in asthma. American Review of Respiratory Disease 143(4 Part 2): A14
Fugazzola, L.; Barbesino, G.; Caturegli, P.; Pacini, F.; Pinchera, A.; Mariotti, S. 1991: Serum soluble interleukin 2 receptor sil 2r levels in differentiated thyroid cancer dtc. European Journal of Cancer 27(Suppl 3): S32
Mckenna, R.M.; Pochinco, D.; Rush, D.; Jeffery, J.R.; Muth, K.; Schroeder, T.J. 1991: Serum soluble interleukin 2 receptor sil2r monitoring in renal transplant recipients rtr. Clinical and Investigative Medicine 14(4 Suppl): A141
Williams, A.J.K.; Symons, J.A.; Watchet, K.; Heading, R.C.; Duff, G.W. 1991: Serum soluble interleukin 2 receptor the best indicator of activity in crohns disease. Gastroenterology 100(5 Part 2): A262
Ryan, J.J.; Dennis, M.J.S.; Porter, C.; Burden, R.P.; Morgan, A.G. 1990: Serum soluble interleukin 2 receptors levels in renal transplant recipients. Nephrology Dialysis Transplantation 5(8): 752
Khosraviani, M.; Davis, S.L. 1994: Serum soluble interleukin-2 receptor activity in the bovine Effect of selenium , vitamin E , and disease status. FASEB Journal 8(4-5): A644
Sentsova, T.B.; Tsygin, A.N.; Ryaposova, A.B.; Sergeeva, T.V. 1998: Serum soluble interleukin-2 receptor and tumor necrosis factor factor-alpha in children with nephrotic syndrome. Allergy 53(Suppl 43): 184
Tsygin, A.N.; Sentsova, T.B.; Gozalishvili, T.V.; Pinelis, V.G. 1997: Serum soluble interleukin-2 receptor and tumor necrosis factor-alpha in childhood nephrotic syndrome. Nephrology Dialysis Transplantation 12(9): A42
Tsygin, A.N.; Sentsova, T.B.; Smirnov, I.E.; Gozalishvili, T.V.; Pinelis, V.G. 1997: Serum soluble interleukin-2 receptor and tumor necrosis factor-alpha in children with steroid-sensitive nephrotic syndrome. Pediatric Nephrology 11(5): C78
Syrigos, K.N.; Stavrakis, I.; Konstantoulakis, M.M.; Syrigou, E.I.; Peveretos, P.; Golematis, B.C. 1998: Serum soluble interleukin-2 receptor pre- and postoperatively in patients with colon adenocarcinoma. Allergy 53(Suppl 43): 135
D.B.uijn, H.W.A.; Ten Hoor, K.A.; Van Der Zee, A.G.J. 1997: Serum soluble interleukin-2 receptor-alpha in patients with epithelial ovarian tumors is related to the cystic fluid levels. Tumor Biology 18(Suppl 2): 133
Cetingül, N.; Yener, E.; Oztop, S.; Nişli, G. 1994: Serum soluble interleukin-2 receptors and tumor necrosis factor-alpha in hematological malignancies of childhood. Acta Paediatrica Japonica: Overseas Edition 36(1): 49-52
Uziel, Y.; Krafchik, B.R.; Feldman, B.; Silverman, E.D.; Laxer, R.M.; Rubin, L.A. 1993: Serum soluble interleukin-2-receptor levels in localized scleroderma. Arthritis and Rheumatism 36(9 Suppl): S54
Omura, H.; Ishiga, K.; Tajima, F.; Kawatani, T.; Kawasaki, H. 1998: Serum soluble interleukin-6 receptor in patients who received peripheral blood stem cell collection. Experimental Hematology 26(8): 714
Chazouilleres, O.; Vaubourdolle, M.; Fourel, V.; Robert, A.; Balladur, P.; Laribi, A.; Giboudeau, J.; Parc, R.; Hannoun, L.; Poupon, R. 1994: Serum soluble thrombomodulin level and creatine kinase-BB activity during orthotopic liver transplantation. Gastroenterology 106(4 Suppl): A874
Means, R.T.Jr; Allen, J.; Sears, D.A.; Schuster, S.J. 1998: Serum soluble transferrin receptor in the diagnosis of iron deficiency in patients with multiple medical problems. Journal of Investigative Medicine 46(3): 213A
D.B.nedetti, F.; Pignatti, P.; Massa, M.; Ravelli, A.; Corti, A.; Cassani, G.; Martini, A. 1994: Serum soluble tumor necrosis factor receptor 1 in juvenile rheumatoid arthritis. Arthritis and Rheumatism 37(9 Suppl): S219
Macario, F.; Paiva, A.; Freitas, L.; Freitas, A.; Martins, R.; Campos, M.; Mota, A.; Breda, H.; Furtado, L.; Marques, A. 1998: Serum soluble values and expression on circulating lymphocytes and neutrophils of ICAM-1 in renal transplantation. Nephrology Dialysis Transplantation 13(6): A261
Kamegaya, Y.; Oda, M.; Yokomori, H.; Komatsu, K.; Miyaguchi, S.; Tsukada, N.; Yonei, K.; Ishii, H. 1996: Serum soluble-ICAM-1 levels and hepatic ICAM-1 expressions in AMA-negative and AMA-positive primary biliary cirrhosis. Hepatology 24(4 Part 2): 530A
Moseley, W.M.; Ichhpurani, A.K.; Alaniz, G.R.; Claflin, W.H.; Reeves, D.R.; Cleary, D.L.; Zantello, M.R. 1993: Serum somatotropin response in meal-fed Holstein steers during iv infusion of growth hormone releasing peptide or growth hormone-releasing factor. Journal of Animal Science 71(Suppl 1): 138
Spalding, S.M.; Bernd, L.A.G.; Wald, V.; Barbiero, J.P.; Ambrozio, L.C. 1997: Serum specific IgE and skin prick test reactivity to D pteronyssinus and B tropicalis A controlled study. Journal of Allergy and Clinical Immunology 99(1 Part 2): S345
Badf Eldin, S.E.D.n A.; Kassem, A.N.srat M. 1994: Serum specific IgG antibody titres to Helicobacter pylori as a monitor of the response to the treatment of the infection. Journal of the Medical Research Institute 15(1): 85-88
Verlooy H.; Devos P.; Janssens J.; Gerits M.; Bonte J.; De Roo M. 1990: Serum squamous cell carcinoma antigen scc ag in carcinoma of the uterine cervix. European Journal of Nuclear Medicine 16(7): 425
Maibuecher, A.; Gottschalk, U.; Menke, H.; Koehnlein, W. 1990: Serum stability of neocarzinostatin and its conjugate with monoclonal antibodies. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 426
W.C.; Brechbiel, M.W.; Mcmurry, T.J.; Pippin, C.G.; Gansow, O.A. 1992: Serum stability studies of bifunctional dtpa and macrocyclic ligands with yttrium 88. Journal of Nuclear Medicine 33(5 Suppl): 1031
Kitazawa, H.; Srsen, V.; Nonoyama, K.'ichi; Saito, T.; Murofushi, H.; Kishimoto, T.; Hisanaga, S.I.hi 1996: Serum starvation Induced dephosphorylation of a cell cycle-independent phosphorylation site at SER696 of MAP4. Cell Structure and Function 21(6): 596
Shin, J.T.; Opalenik, S.R.; Mahesh, V.K.; Nan, S.; Thompson, J.A. 1994: Serum starvation induces secretion of FGF-1 from primary fibroblasts. Journal of Cellular Biochemistry Suppl 1994(18 Part A): 330
Epp,M.P.; Blasi,D.A.; Johnson,B.J.; Kayser,J.P.; Grieger,D.M.; Stevenson,J.S.; Minton,J.E. 2008: Serum steroid concentrations at different phases of production and brain monoamine oxidase type A messenger ribonucleic acid in buller steers. Professional Animal Scientist: 6, 552-559
Roberts, E.; Fitten, L.J. 1990: Serum steroid levels in two old men with alzheimers disease ad before during and after oral administration of dehydroepiandrosterone dhea pregnenolone synthesis may become rate limiting in aging. Kalimi, M And W Regelson The Biologic Role Of Dehydroepiandrosterone (Dhea) Viii+450p Walter De Gruyter And Co : Berlin, Germany; Hawthorne, New York, Usa Illus 43-64
Clementson, J.; Jones, S.J.; Markham, A.; Morgan, R.M.; Wood, M. 1989: Serum stimulated respiration in staphylococci. Journal of Applied Bacteriology 67(6)
Stein, G.H.; Robetorye, R.S.; Drullinger, L.F.; Pereira Smith, O.M.; Smith, J.R. 1990: Serum stimulated senescent human fibroblasts fail to express the cdc2hs gene. Journal of Cell Biology 111(5 Part 2): 498A
Silverman, E.S.; Goslant, C.E.; Quinn, D.A.; Bonventre, J.V.; Joseph, P.M.; Thompson, B.T.; Hales, C.A. 1994: Serum stimulates Na+/H+ exchange in human pulmonary artery smooth muscle cells by increasing the PK-05 and decreasing the hill coefficient of the allosteric internal modifier site. FASEB Journal 8(4-5): A120
Strieleman, P.J.; Connors, M.; Metzger, B.E. 1991: Serum stimulates phosphoinositide hydrolysis in the 105 day cultured postimplantation rat conceptus. FASEB Journal 5(5): A1175
Oi, M.; Eleftheriades, E.G.; Ojamaa, K.; Klein, I.; Samarel, A.M. 1992: Serum stimulation and contractile activity modulate growth and myosin heavy chain-beta isoenzyme content in cultured neonatal rat heart cells. Molecular Biology of the Cell 3(Suppl ): 247A
Kobayashi, J.; Zhu, L.; Rabinovitch, M. 1993: Serum stimulation of elastase in vascular smooth muscle cells. FASEB Journal 7(3-4): A795
Waysbort, Y.; Tanay, A.; Askenazy, B. 1993: Serum striated muscle enzymes in autoimmune hypoparathyroidism. Harefuah 125(10): 341
Cussenot, O.; Villette, J.M.; Cariou, G.; Desgrandchamps, F.; Cortesse, A.; Boudou, P.; Soliman, H.; Teillac, P.; Fiet, J.; Le Duc, A. 1994: Serum studies of chromogranin A, neurone specific enolase , substance P as markers in patients with benign prostate hyperplasia and prostatic carcinoma. Journal of Urology 151(5 Suppl): 297A
Albengres, E.; Abuaf, N.; Gauthier, F.; Daghfous, R.; Guichoux J Y.; Tillement, J.P. 1990: Serum studies of sensitization induced by contraceptive drugs results of a controlled study. Therapie (London/Paris) 45(1)
Sasaki, Y.; Ueda, H.; Fukushima, N.; Okada, T.; Misu, Y. 1995: Serum substitutes for endogenous factors involved in cell density-dependent survival of rat cortical neurons. Society for Neuroscience Abstracts 21(1-3): 1788
Komaromy Hiller, G.; Farnsworth, J.R.; Jacobson, L.J.; Nuttall, K.L. 1997: Serum succinate elevation in pathological conditions. Clinical Chemistry 43(6 Part 2): S113
Tekin, M.; Akar, N.; Eğin, Y.; Cin, S. 1998: Serum superoxide dismutase levels of beta thalassemia patients and effects of high dosage of intravenous desferrioxamine treatment on superoxide dismutase levels. Pediatric Hematology and Oncology 15(4): 371-374
Gibson, P.R.; Kagelari, O.; Young, G.P. 1992: Serum suppresses the constitutive expression of phenotypic markers of differentiation in colonic epithelium. Gastroenterology 102(4 Part 2): A357
Yu, S.; Nakafusa, Y.; Flye, M.W. 1993: Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells. Transplantation Proceedings 25(1 Part 1): 500-501
Barral Netto, M.; Santos, S.B.; Barral, A.; Pedral Sampaio, D.; Badaro, R.; Carvalho, E.M. 1990: Serum suppressor factors in children infected by leishmania chagasi in an endemic area of visceral leishmaniasis. Memorias do Instituto Oswaldo Cruz 85(Suppl 1): 92
Nomori, H.; Horio, H.; Fuyuno, G.; Kobayashi, R.; Morinaga, S.; Suemasu, K. 1998: Serum surfactant protein a levels in healthy individuals are increased in smokers. Lung 176(6): 355-361
Kobayashi, H.; Kanoh, S.; Motoyoshi, K. 2008: Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 13(4): 385-392
Mishu, B.; Blaser, M.J. 1994: Serum susceptibility of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome. Abstracts of the General Meeting of the American Society for Microbiology 94: 53
Smith, G.S.; Edrington, T.S.; Kiehl, D.E.; Stavanja, M. 1992: Serum swainsonine clearance and serum component changes in bovines dosed intraruminally with locoweed. Journal of Animal Science 70(Suppl 1): 123
Miyagawa, N.; Fujii, T.; Kimura, Y.; Hamamoto, K.; Ueda, N. 1989: Serum ta 4 level and its immunohistological localization of squamous cell carcinoma of the lung and other organs. Journal of Nuclear Medicine 30(5 Suppl): 918
Correale, M.; Abbate, I.; Gargano, G.; Garrubba, M.; Muncipinto, A.; Addabbo, L.; Colangelo, D. 1991: Serum TAG 72 levels in different human carcinomas. International Journal of Radiation Applications and Instrumentation. Part B Nuclear Medicine and Biology 18(1): 101-103
Yoshikawa, H.; Uchida, A.; Kudawara, I.; Ono, K. 1992: Serum tartrate resistant acid phosphatase as a tumor marker in giant cell tumor of bone. Calcified Tissue International 50(Suppl 1): A43
Malluche, H.H.; Juvin, R.; Allen, S.H.; Faugere, M.C. 1991: Serum tartrate resistant acid phosphatase reflects osteoclastic resorption better than pth in dialyzed patients. Journal of the American Society of Nephrology 2(3): 337
Gerakis, A.; Nicolou, C.; Apostolou, T.; Parasiris, J.; Billis, A. 1993: Serum tartrate-resistant acid phosphatase does not correlate with the histological findings of renal osteodystrophy. Nephrology Dialysis Transplantation 8(9): 911
Preston, M.J.; Berk, R.S.; Hazlett, L.D. 1991: Serum tear and cornea antibody levels during pseudomonas aeruginosa corneal infection. Abstracts of the General Meeting of the American Society for Microbiology 91: 131
Richmond, R.; Mcrorie, E.R.; Salter, D.M.; Dunne, E.; Nuki, G. 1996: Serum tenascin levels in patients with rheumatoid and psoriatic arthritis. British Journal of Rheumatology 35(ABSTR Suppl 1): 176
Von Der Pahlen, B.; Ost, B.; Eriksson, C.J.P. 1990: Serum testosterone cortisol glucose and ethanol in males arrested for family violence. Alcoholism Clinical and Experimental Research 14(2): 311
Shimomitsu, T.; Iwane, H.; Katsumura, T.; Takanami, Y.; Ohya, Y. 1991: Serum testosterone cortisol ratio t c as an indicator of severity of physical stress in ultraendurance exercise. Medicine and Science in Sports and Exercise 23(4 Suppl): S122
Garanina, Z.; Simeonov, A.; Stantcheva, J.; Tzingilev, D. 1990: Serum testosterone level in men with lung cancer. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 122
Ishikawa, A.; Ushiyama, T.; Suzuki, K.; Fujita, K. 1996: Serum testosterone levels after renal transplantation. Transplantation Proceedings 28(3): 1952-1953
Boutsen, Y.; Donckier, J.; Delaunois, L.; Sibille, Y.; Weynants, P.; Esselinckx, W. 1993: Serum testosterone levels during glucocorticoid therapy in men with chronic bronchitis. European Journal of Clinical Investigation 23(Suppl 1): A13
Snyder, A.C.; Foster, C.; Woulfe, T.; Welsh, R. 1990: Serum testosterone levels following heavy training. Medicine and Science in Sports and Exercise 22(2 Suppl): S66
Dobs, A.S.; Burnett, A.L.; Fagan, P.J.; Allen, R.P. 1995: Serum testosterone levels of men with erectile dysfunction presenting to a general urology clinic. Journal of Andrology 1995(Suppl ): P56
Ratnasooriya, W.D.; Fernando, S.B.U.; Manatunga, A.M.V.R. 1992: Serum testosterone levels of sri lankan female elephants elephas maximus maximus. Medical Science Research 20(2): 79-80
Pangawkar, G.R.; Sharma, R.D.; Dugwekar, Y.G. 1989: Serum testosterone profiles in exotic and crossbred bulls with different freezability and initially poor quality semen. Indian Journal of Animal Sciences 59(10): 1279-1280
Bong, G.W.; Clarke, H.S.; Hancock, W.C.; Keane, T.E. 2008: Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer. Urology 71(6): 1177-1180
Trojan, J.; Raedle, J.; Zeuzem, S. 1998: Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment. Digestion 59(Suppl 2): 72-74
Palma, C.; Ray, C.; Lowrance, J.; Gresham, H.; O'sullivan F. 1991: Serum tgf b levels correlate with increased susceptibility to lethal infection in mri lpr mice. Clinical Research 39(3): 703A
Cooper, R.; Huang, D.; Harman, E.; Blake, K.; Hendeles, L. 1991: Serum theophylline concentration fluctuations with a new once a day product. Annals of Allergy 66(1): 96
Iikura, Y.; Hashimoto, K.; Akasawa, A.; Katsunuma, T.; Ebisawa, M.; Saito, H.; Sakaguchi, N.; Matsumoto, K.; Nonomura, K.; Soda, A.; Koya, N. 1996: Serum theophylline concentration levels and preventative effects on exercise-induced asthma. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 26 Suppl. 2: 38-41
Glatman-Freedman, A.; Casadevall, A. 1998: Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clinical Microbiology Reviews 11(3): 514-532
Von Behring, E. 1989: Serum therapy in the science and art of healing. Scandinavian Journal of Immunology 30(1): 6-12
Anderson, K.; Watson, I.; Bourke, S.; Mcsharry, C.; Moran, F.; Boyd, G. 1989: Serum thiocyanate and environmental lung disease influenced by cigarette smoking. American Review of Respiratory Disease 139(4 Part 2): A27
Googins, M.K.; Lowe, M.; Kloss, J.; Apple, F. 1996: Serum thiocyanate concentrations in normal and renal impaired patients receiving nitroprusside. Clinical Chemistry 42(6 Part 2): S208
Spagnolo, A.; Menotti, A.; Giampaoli, S. 1989: Serum thiocyanate levels as an objective measure of smoking habits. European Heart Journal 10(ABSTR Suppl): 219
Schienle, H.W.; Kreis, I.; Treugut, H.; Fetzer, I.; Sanders, S.; Hofer, T.; Seitz, R.; Nawroth, P. 1995: Serum thrombomodulin level in patients with thromboembolism and different diseases. Annals of Hematology 70(Suppl 1): A30
Tanaka, M.; Kobayashi, S.; Shiomi, H.; Kazama, M.; Kawano, T.; Hashimoto, H.; Hirose, S.I.hi 1992: Serum thrombomodulin levels in systemic lupus erythematosus Correlation with anticardiolipin antibodies. Arthritis and Rheumatism 35(9 Suppl): S110
Tacke, F.; Schoeffski, P.; Ganser, A.; Trautwein, C.; Martin, M.U.; Seifried, E.; Manns, M.; Stangel, W.; Petersen, D. 1998: Serum thrombopoiesis-promoting growth factor levels and thrombopoietin reference interval in healthy whole-blood and platelet donors. Blood 92(10 Suppl 1 Part 1-2): 564A
Satoi, J.; Sanjyou, Y.; Takekuma, A.; Nekohashi, T.; Abe, T.; Tsuboi, Y.; Suzuki, N.; Kato, T.; Tahara, T.; Tanaka, T. 1997: Serum thrombopoietin and hepatosplenomegaly in patients with chronic liver disease. Hepatology 26(4 Part 2): 206A
Urabe, A.; Usuki, K.; Okazaki, R.; Iki, S.; Totsuka, Y. 1998: Serum thrombopoietin level in Graves disease. Experimental Hematology 26(8): 769
Hisatomi, K.; Sezai, S.; Ishikawa, A.; Ito, M.; Sakurai, Y.; Kamisaka, K. 1998: Serum thrombopoietin level regulated by portal hemodynamics in liver cirrhosis. Gastroenterology 114(4 Part 2): A1256
Maharaj, D.; Steinberg, J.; O'neill, G.J.; Mccoy, K.; Gouvea, J.; Nichol, J. 1996: Serum thrombopoietin levels correlate with CD34+ subsets predictive of rapid platelet recovery post-autologous peripheral blood stem cell transplant and may optimize the timing of PBSC harvest. Blood 88(10 Suppl 1 Part 1-2): 401A
Kitano, K.; Shimodaira, S.; Ichikawa, N.; Ishida, F.; Ito, T.; Tahara, T.; Kato, T.; Kiyosawa, K. 1997: Serum thrombopoietin levels during the long-term clinical course of haemophiliacs with hepatitis C virus and HIV-1 CO-infection who died of hepatic failure and AIDS. Blood 90(10 Suppl 1 Pt 2): 85B
Araneda, M.; Krishnaswamy, G.; Krishnan, V.; Hall, K.; Krishnan, K. 1998: Serum thrombopoietin levels in disorders of thrombocytopenia Implications for future use of recombinant TPO in clinical practice. Blood 92(10 Suppl 1 Part 1-2): 31A
Tahara, T.; Usuki, K.; Sato, H.; Ohashi, H.; Morita, H.; Miyazaki, H.; Urabe, A.; Kato, T. 1995: Serum thrombopoietin levels in healthy volunteers and patients with various disorders measured by immunoassay. Blood 86(10 Suppl 1): 910A
Wang, J.C.; Chen, C.; Nicol, J. 1996: Serum thrombopoietin levels in patients with essential thrombocytosis and reactive thrombocytosis. Blood 88(10 Suppl 1 Part 1-2): 212B
Kato, N.; Shiratori, Y.; Nita, S.; Shiina, S.; Ehata, T.; Yokosuka, O.; Omata, M. 1996: Serum thrombopoietin levels in patients with fulminant hepatitis. Hepatology 24(4 Part 2): 334A
Shimodaira, S.; Ishida, F.; Ichikawa, N.; Tahara, T.; Kato, T.; Kodaira, H.; Ito, T.; Tanaka, E.; Sodeyama, T.; Kiyosawa, K.; Kitano, K. 1995: Serum thrombopoietin levels in patients with liver cirrhosis. Blood 86(10 Suppl 1): 908A
Simsek, H.; Kadayifci, A.; Kirazli, S. 1997: Serum thromboxane B2 levels in Familial Mediterranean fever. Gastroenterology 112(4 Suppl): A1189
Martynova, M.I.; Arion, V.Y.; Smirnov, V.V.; Doroshenko, E.O.; Pilyutik, V.F. 1994: Serum thymic activity in children with insulin-dependent diabetes mellitus. Pediatriya (Moscow) 1994(3): 20-22
Onodera, T.; Yoshihara, K.; Suzuki, T.; Tsuda, T.; Ikeda, T.; Awaya, A.; Kobayashi, H.; Yukawa, M. 1993: Serum thymic factor limits pseudorabies virus replication in mice. Veterinary Immunology and Immunopathology 35(Suppl ): 122
Lafeuillade, A.; Quilichini, R.; Vidal, J.; Delbeke, E.; Chaffanjon, P.; Aubert, L. 1991: Serum thymidine kinase a prognostic marker in human immunodeficiency virus infection. Semaine des Hopitaux 67(17): 587-590
Tarrand, J.; Yau, J.; Lemaister, C.; Wallerstein, R.; Anderson, B.; Fritsche, H.Jr 1992: Serum thymidine kinase in allogeneic marrow transplant patient and correlation with cytomegalovirus viremia. Abstracts of the General Meeting of the American Society for Microbiology 92: 445
Suehiro, M.; Fukuchi, M.; Tachibana, K.; Kitani, H. 1991: Serum thymidine kinase in bone marrow transplant patients a possible marker for monitoring the effect of transplantation. Journal of Nuclear Medicine 32(5 Suppl): 1087-1088
Uhr, E.; Brown, E.D.; Joshua, D. 1990: Serum thymidine kinase in patients with multiple myeloma. Australian Journal of Medical Laboratory Science 11(4): 160
Hallek, M.; Touitou, Y.; Levi, F.; Bogdan, A.; Mechkouri, M.; Bailleul, F.; Senekowitsch, R.; Emmerich, B. 1993: Serum thymidine kinase levels are elevated in patients with ovarian cancer and exhibit important circadian variations. Annals of Hematology 67(Suppl ): A45
Nowrousian, M.R.; Nagel Hiemke, M.; May, D.; Niederle, N.; Maschmeyer, G.; Schmidt, C.G. 1989: Serum thymidine kinase s tk in acute leukemias and chronic myeloproliferative diseases. Proceedings of the American Association for Cancer Research Annual Meeting 30: 230
Migdal, S.D.; Mutchnick, M.G.; Mahajan, S.K.; Abu Hamdan, D.K.; Mcdonald, F.D. 1989: Serum thymosin b 4 tb 4 levels in patients with chronic renal failure cfr. Kidney International 35(1): 198
D.L.L.z Ruiz Reyes, M.; Maritza Garcia, F.; Martinez, G.M.P.a; Gonzalez, A.P.R.; Altamirano, N.B.; Schiavon, R.E.; Robles, C.V.; Calzada, R.L.on 1997: Serum thyroglobulin determinations in aplasia and ectopic thyroid tissue in patients with congenital hypothyroidism. Hormone Research 48(Suppl 2): 161
Sack, J. 1989: Serum thyroglobulin in congenital hypothyroidism. Pediatric Research 25(4 Part 2): 92A
Suzuki, S.; Fujikura, K.; Shimoda, Y. 1990: Serum thyroglobulin in metamorphosing tadpoles. Zoological Science 7(6): 1153
Hotze, A.; Bockisch, A.; Ruhlmann, J.; Gruenwald, F.; Biersack, H.J. 1989: Serum thyroglobulin in nontoxic goiter. European Journal of Nuclear Medicine 15(8): 520
Parkes, A.B.; Black, E.; Richards, C.J.; Hall, R.; Lazarus, J.H. 1993: Serum thyroglobulin levels reflect autoimmune thyroid damage in postpartum thyroiditis. Journal of Endocrinology 137(Suppl ): P214
Rapaport, R.; Skuza, K.; Goldstein, S.; Southard, C.; Mayes, D. 1990: Serum thyroglobulin tg levels in normal and hypothyroid infants. Pediatric Research 27(4 Part 2): 84A
Jouko, I.T.I.; Airaksinen, J.; Repo, M.; Pakarinen, A.; Salmela, P.; Myllyla, V.V. 1991: Serum thyroid hormones and myocardial function in patients with epilepsy treated with carbamazepine. Epilepsia 32(Suppl 1): 75-76
Gaffield, J.W.; Dratman, M.B. 1992: Serum thyroid stimulating hormone tsh falls in response to intake of a mixed meal. American Journal of Clinical Nutrition (Suppl): ABSTRACT 153
Ehrmann, D.A.; Sarne, D.H. 1989: Serum thyrotropin and the assessment of thyroid status. Annals of Internal Medicine 110(3): 179-181
Stockigt, J.R. 1996: Serum thyrotropin and thyroid hormone measurements and assessment of thyroid hormone transport. Braverman, L E, Utiger, R D Werner and Ingbar's the thyroid: A fundamental and clinical text, Seventh edition 377-396
Konno, N.; Taguchi, H.; Miura, K.; Taguchi, S.; Murakami, S. 1993: Serum thyrotropin concentration in apparently healthy adults, in relation to urinary iodide concentration. Clinical Chemistry 39(1): 174-175
Harvey, R.D.; Mchardy, K.C.; Trainer, P.J.; Reid, I.W. 1990: Serum thyrotropin tsh is a poor indicator of incipient hypothyroidism in the first six months after radioiodine treatment for thyrotoxic graves disease. Journal of Endocrinology 124(Suppl)
Schoeman, J.P.; Herrtage, M.E. 2008: Serum thyrotropin, thyroxine and free thyroxine concentrations as predictors of mortality in critically ill puppies with parvovirus infection: a model for human paediatric critical illness?. Microbes and Infection 10(2): 203-207
Hsu, C.H.; Lee, L.S.; Chang, J.J.; Liao, S.T.; Chen, S.M.; Hwang, J.Y.; Lo, N.I. 1995: Serum thyrotropin-binding inhibiting immunoglobulin and thyroperoxidase antibody in Graves' hyperthyroidism after 131i therapy. Journal of the Formosan Medical Association 94(1-2): 5-9
Darshan, N.; Panda, J.N.; Varshney, V.P.; Shrivastava, A.K. 1989: Serum thyroxine and triiodothyronine levels in laying and non laying quails. Indian Journal of Animal Sciences 59(8): 965-967
Dyck, G.W. 1991: Serum thyroxine triiodothyronine insulin and glucose during early pregnancy in the gilt. Canadian Journal of Animal Science 71(4): 1293
Van Poppel, H.P.; Elgamal, A.; Billen, J.; Blanckart, N.; Baert, L.V. 1997: Serum tissue polypeptide antigen A valuable marker for monitoring the transitional cell carcinoma. Anticancer Research 17(6C): 4203-4204
Bennink, R.; Billen, J.; Decoster, M.; Van Poppel, H.; Baert, L.; Blanckaert, N.; Mortelmans, L. 1998: Serum tissue polypeptide antigen Mono-clonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer. Journal of Nuclear Medicine 39(5 Suppl): 269P
Basso, D.; Fabris, C.; Piccoli, A.; Plebani, M.; Del Favero, G. 1989: Serum tissue polypeptide antigen in pancreatic cancer and other gastrointestinal diseases. Journal of Clinical Pathology 42(5): 555
Aloe, S.; Roselli, M.; Abbolito, M.R.; Ferroni, P.; D'alessandro, R.; Botti, C.; Cavaliere, F.; Sega, F.; Vici, P.; Perri, P.; Carone, M.D.; Biccari, V.; Carlini, S.; Guadagni, F. 1998: Serum tissue polypeptide specific antigen as a complementary tumor marker to CA 153 in the management of breast cancer. Anticancer Research 18(6C): 4986-4987
Tarle, M.; Kastelan, M.; Kovacic, K. 1992: Serum tissue polypeptide specific antigen values in comparison with tumor load marker and NK activity data in various prostatic tumors. Anticancer Research 12(6A): 1832
Mccall, J.L.; Parry, B.R.; Tuckey, J.A. 1991: Serum tnf alpha and insulin resistance in patients with gastrointestinal cancer. Proceedings of the University of Otago Medical School 69(2): 21-22
Akizawa, T.; Takahashi, J.; Yone, K. 1991: Serum tnf alpha concentration in hemodialysis patients effects of dialysis procedures. Japanese Journal of Artificial Organs 20(2): 420-424
Kivihya, L.E.; Ochola, J.J.; Otieno, G.F.; Gathua, S.; Muthami, L.; Were, J.B. 1992: Serum tnf alpha levels in hiv pulmonary tuberculosis patients. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : a59
Miller, L.C.; Sisson, B.A.; Dinarello, C.A.; Schaller, J.G.; Cannon, J.G. 1991: Serum tnf in childhood dermatomyositis dms relates to disease activity. Cytokine 3(5): 492
Offner, F.; Philippe, J.; Vogelaers, D.; Colardyn, F.; Leroux Roels, G. 1990: Serum tnf levels in medical intensive care unit patients with severe infectious disease. Circulatory Shock 31(2): 230
Palazzolo, M.; Braun, T.; Liebergen, A.; Shaw, P.; Conerys, K.; Leff, R. 1995: Serum tobramycin pharmacokinetics following high-dose, aerosolized delivery in cystic fibrosis patients. Journal of Investigative Medicine 43(Suppl 3): 440A
Njeru, C.A.; Mcdowell, L.R.; Wilkinson, N.S.; Williams, S.N.; Lentz, E.L. 1991: Serum tocopherol in sheep after intramuscular injection of racemic alpha tocopherol. Journal of Animal Science 69(Suppl 1): 545
Chu, L.-W.; Tam, S.; Kung, A.W.C.; Lo, S.; Fan, S.; Wong, R.L.C.; Morley, J.E.; Lam, K.S.L. 2008: Serum total and bioavailable testosterone levels, central obesity, and muscle strength changes with aging in healthy Chinese men. Journal of the American Geriatrics Society 56(7): 1286-1291
Salehian, B.; Hikim, I.S.; Louie, J.; Bhasin, S. 1998: Serum total and free testosterone levels in women with systemic lupus erythematosus, measured by highly sensitive assays. Journal of Investigative Medicine 46(1): 140A
Vivas, I.; Spagnuolo, L.; Palacios, P. 1990: Serum total and lipid bound sialic acid as tumor markers in carcinoma of the uterine cervix. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 264
Nakamura, H.; Yonetani, M.; Miyake, O.; Lee, Y.; Funato, M.; Hosono, S. 1997: Serum total and unbound bilirubin levels and neurological signs in Japanese hyperbilirubinemic infants. Pediatric Research 41(4 Part 2): 166A
Brown, A.; Dugdill, S.; Wyatt, M.; Mantle, D. 1998: Serum total antioxidant status during vascular surgery. Biochemical Society Transactions 26(2): S127
Clavo, B.; Aguilar, J.A.; Veiga, E.; Rey Baltar, D.; Lloret, M.; Santana, A.; Salas, R.; Macias, D.; Hernandez, M.A.; Puig Parellada, P. 1998: Serum total antioxidant status in cancer patients. Journal of Investigative Medicine 46(3): 214A
Morselli Labate, A.M.; Malavolti, M.; Sama, C.; Zamboni, L.; Talarico, R.; Cicognani, C.; Barbara, L. 1993: Serum total bile acids are inversely related to serum HDL cholesterol levels after ursodeoxycholic acid treatment in man. Journal of Hepatology 18(Suppl 1): S151
Aronow, W.S. 1992: Serum total cholesterol in atherothrombotic brain infarction. Journal of the American Geriatrics Society 40(7): 734
Senthilkumar, P.; Rajasundaram, R.C.; Selvaraju, M.; Kathiresan, D. 1998: Serum total cholesterol level and its relationship with number of ovulation in superovulated Tellicherry goats. Indian Journal of Animal Sciences 68(3): 247-248
Marniemi, J.; Jula, A.; Seppanen, R.; Rastas, M.; Toikka, T. 1997: Serum total fatty acid composition as a biochemical marker of dietary fat during reduced fat intake. American Journal of Clinical Nutrition 65(4 Suppl): 1350S
Whincup, P.H.; Refsum, H.; Perry, I.J.; Morris, R.; Lennon, L.; Walker, M.; Thomson, A.; Ueland, P.M.; Ebraim, S. 1998: Serum total homocysteine and coronary heart disease Prospective study in middle aged men. Netherlands Journal of Medicine 52(Suppl ): S36
Cui, R.; Moriyama, Y.; Koike, K.A.; Date, C.; Kikuchi, S.; Tamakoshi, A.; Iso, H. 2008: Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study. Atherosclerosis 198(2): 412-418
Adebayo, K.J.; Madu, E.F.; Adebayo-Kay, V.C. 2008: Serum total homocysteine concentrations in children and adolescents in Jos, Nigeria. Journal of Tropical Pediatrics 54(4): 282-283
Drzewoski, J.; Czupryniak, L.; Chwatko, B.; Bald, E. 1998: Serum total homocysteine levels in non-insulin dependent diabetics at the start of insulin therapy. Diabetologia 41(Suppl 1): A336
Yeh, L.L.; Kuller, L.H. 1997: Serum total lipid fatty acid weight composition as a potential biochemical marker for fat intake in a low-fat diet intervention trial. American Journal of Clinical Nutrition 65(4 Suppl): 1354S
Hirakata, H.; Onoyama, K.; Fujimi, S.; Hasuo, Y.; Fujishima, M. 1990: Serum total protein as a prognostic index in diabetic dialysis patients. Kidney International 37(1): 301
Summanen, P.; Makimattila, S.; Matinlauri, I.; Mantysaari, M.; Yki Jarvinen, H. 1996: Serum total renin, an independent new marker of active diabetic retinopathy. Diabetologia 39(Suppl 1): A243
Soler, L.; Martínez-Subiela, S.; Tecles, F.; Gutierrez, A.; Fuentes, P.; Cerón, J.Joaquín. 2008: Serum total sialic acid in pigs: new possibilities for an old inflammatory biomarker. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians Inc 20(6): 799-803
Crook, M.; Lumb, P.; Andrews, V.; Swaminathan, R. 1998: Serum total sialic acid, a reputed cardiovascular risk factor, and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals. Clinical Science 95(1): 53-57
Jamil, K.M. 1990: Serum trace elements as diagnostic and prognostic tool in iraqi cancer patients. Clinical Chemistry 36(6): 1056
Obara, H.; Tomite, Y.; Doi, M. 2008: Serum trace elements in tube-fed neurological dysphagia patients correlate with nutritional indices but do not correlate with trace element intakes: case of patients receiving enough trace elements intake. Clinical Nutrition 27(4): 587-593
Pramoolsinsap, C.; Promvanit, N.; Komindr, S.; Lerdverasirikul, P.; Srianujata, S. 1994: Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand. Journal of Gastroenterology 29(5): 610-615
Mackenzie, I.R.A. 1996: Serum trace metals in patients with Alzheimer-type senile plaques. Trace Elements and Electrolytes 13(2): 107-108
Foster, L.; Spendlove, R.; Baker, J.; Chung, B. 1991: Serum traceability. American Biotechnology Laboratory 9(9): 26-27
Barnett, C.P.; Ekert, P.G.; Perlman, M. 1996: Serum transaminase measurements in post-asphyxial hypoxic ischemic encephalopathy. Pediatric Research 39(4 Part 2): 293A
Martin, D.A.gila, C.; Boixeda, D.; Canton, R.; Garcia, M.; Barcena, R.; Gisbert, J.P.; Ramos, F.; Garcia Plaza, A. 1998: Serum transaminases and Helicobacter pylori infection. Gastroenterology 114(4 Part 2): A218
Areekul, S.; Churdchu, K.; Cheeramakara, C.; Wilairatana, P.; Charoenlarp, P. 1995: Serum transcobalamin Ii levels in patients with acute and chronic renal failure. Journal of the Medical Association of Thailand 78(4): 191-196
Tinnikov, A.A.; Legan, M.V. 1994: Serum transcortin levels in children during heart surgery. European Journal of Endocrinology 130(Suppl 2): 108
Araneo, B.; Huang, K.; Griffiths, M.; Eichwald, E.J. 1990: Serum transfer, anaphylactic shock, and the role of fetal calf serum. Transplantation 49(4): 837-838
Bobilewicz, D.; Kozlowska, A.; Krawczynski, J.; Pertkiewicz, M. 1990: Serum transferrin and ferritin response to acute phase reaction in parenterally fed patients. Clinical Chemistry 36(6): 968
Fafutis, M.; Alfaro, F.; Gonzalez, A.; Santoscoy, L.; Barba Rubio, J.; Morales, R.; Islas, A. 1993: Serum transferrin concentration and Tf receptors on the surface of T lymphocytes in lepromatous leprosy. International Journal of Leprosy and Other Mycobacterial Diseases 61(4 Suppl): 101A
Kuvibidila, S.; Warrier, R.P.; Yu, L.; Ode, D. 1993: Serum transferrin levels in Zairean pregnant women with and without hepatitis B virus infection. FASEB Journal 7(3-4): A274
Ahluwalia, N.; Skikne, B.S.; Savin, V.J.; Chonko, A.M.; Cook, J.D. 1993: Serum transferrin receptor and automated reticulocyte count are early markers of response to recombinant human erythropoietin. Journal of the American Society of Nephrology 4(3): 423
Skikne, B.S.; Ahluwalia, N.; Savin, V.; Chonko, A.; Cook, J.D. 1993: Serum transferrin receptor and automated reticulocyte counts are early markers of marrow response to recombinant human erythropoietin. Blood 82(10 Suppl 1): 93A
Manteiga, R.; Remacha, A.F.; Munoz, L.; Sarda, M.P.; Ubeda, J.; Parellada, M. 1998: Serum transferrin receptor in different hematological disorders. British Journal of Haematology 102(1): 42
Remacha, A.F.; Sarda, M.P.; Ubeda, J.; Parellada, M.; Manteiga, R. 1998: Serum transferrin receptor in the diagnosis of iron deficiency anemia. British Journal of Haematology 102(1): 43
Remacha, A.F.; Sarda, M.P.; Ubeda, J.; Parellada, M.; Manteiga, R. 1998: Serum transferrin receptor in the differential diagnosis of iron deficiency. Blood 92(10 Suppl 1 Part 1-2): 22B
Zeki Tonbul, H.; Kaya, H.; Selçuk, Y.; San, A.; Akçay, F.; Tekin, S.B. 1998: Serum transferrin receptor level in the diagnosis of iron deficiency due to erythropoietin treatment. Nephron 80(2): 241
Kling, P.J.; Roberts, R.A.; Widness, J.A. 1994: Serum transferrin receptor levels correlate with indices of erythropoiesis and iron in normal infants. Pediatric Research 37(4 Part 2): 160A
Feelders, R.A.; Vreugdenhil, G.; Manger, B.; van Eijk, H.G.; Swaak, A.J. 1994: Serum transferrin receptor levels in anaemia of rheumatoid arthritis and effects of iron chelation treatment. European Journal of Haematology 52(1): 61-62
Kling, P.; Roberts, R.A.; Widness, J.A. 1995: Serum transferrin receptor levels, iron induces and erythropoiesis in normal term infants. Journal of Investigative Medicine 43(Suppl 1): 173A
Punnonen, K.; Irjala, K.; Rajamäki, A. 1998: Serum transferrin receptor, ferritin and TfR-F index in identification of latent iron deficiency. European Journal of Haematology 60(2): 135-137
Fourtounas, C.; Kapetanaki, A.; Dalamangas, A.; Malegos, J.; Kopelias, J.; Iatrou, C.; Tzanatos, H.; Papadodimas, N.; Ziroyannis, P.; Agroyannis, B. 1998: Serum transferrin receptor/ferritin ratio as a marker of iron deficiency in dialysis patients. Nephrology Dialysis Transplantation 13(6): A244
Colton, C.; Geraci, K.; Tahsildar, H.; Flowers, C.; Cook, J.; Cooper, G.; Hornbuckle, K. 1995: Serum transferrin receptor/ferritin ratio is a reliable predictor of iron deficiency anemia in inflammatory bowel disease patients. Gastroenterology 108(4 Suppl): A800
Deira, J.; Martin, M.; Sanchez, S.; Martin, B.; Tabernero, J.M. 1996: Serum transferrin receptors and iron kinetics of 59FE as indicators of erythropoietic activity in patients on hemodialysis treated with EPOrHu. Nephrology Dialysis Transplantation 11(6): A269
Longmate, R.; Davenport, A.; Smith, N. 1998: Serum transferrin receptors are not useful as markers of functional iron deficiency in haemodialysis patients treated with erythropoeitin. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 218A
Ricerca, B.M.; Tartaglione, R.; Candido, A.; Mancini, R.; Bussa, S.; Alfano, G.; Storti, S.; Bizzi, B. 1992: Serum transferrin receptors in chronic lymphocytic leukemia. Acta Medica Romana 30(3-4): 255-257
Raja, K.B.; Keating, J.; Davis, K.; Sherwood, R.; Peters, T.J. 1998: Serum transferrin-receptor status in alcoholism. Alcoholism Clinical and Experimental Research 22(3 ABSTR Suppl ): 181A
Leow, C.K.; Lau, W.Y.; Ip, S.M.; Leung, N.; Li, A.K.C. 1995: Serum transforming growth factor alpha in hepatitis B virus carrier and cirrhotics. Hepatology 22(4 Part 2): 446A
Tomiya, T.; Ogata, I.; Fujiwara, K. 1997: Serum transforming growth factor alpha levels may reflect the degree of liver regeneration. European Journal of Clinical Investigation 27(Suppl 1): A13
Coskun, H.S.; Ilhan, O.; Ozcan, M.; Ayaz, S.; Dalva, K.; Ustun, C.; Arat, M.; Beksac, M. 1998: Serum transforming growth factor beta 1 levels in multiple myeloma. Blood 92(10 Suppl 1 Part 1-2): 262B
Law, N.M.; Lim, C.C.; Tan, C.K.; Lai, O.F.; Ng, H.S. 1996: Serum transforming growth factor-alpha in hepatocellular carcinoma. Hepatology 24(4 Part 2): 536A
Tomiya, T.; Hayashi, S.; Yanase, M.; Umeda, N.; Tani, M.; Yamada, S.; Masaki, N.; Ogata, I.; Fujiwara, K. 1997: Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer. Seminars in Oncology 24(2 Suppl 6: S6
Grainger, D.J.; Metcalfe, J.C.; Parameshwar, J.; Grace, A.A.; Wallwork, J.; Schofield, P.M.; Chauhan, A. 1995: Serum transforming growth factor-beta levels do not correlate with the coronary occlusive disease following cardiac transplantation. European Heart Journal 16(ABSTR Suppl ): 229
D'argenio G.; Ciacci, C.; Sorrentini, I.; Cosenza, V.; Iovino, P.; Gatto, A.; Mazzacca, G. 1989: Serum transglutaminase activity in patients affected with ulcerative colitis. Gastroenterology 96(5 Part 2): A110
D'argenio G.; Biancone, L.; Sorrentini, I.; Cosenza, V.; Deritis, F.; Boirivant, M.; Pallone, F.; Mazzacca, G. 1992: Serum transglutaminase and crohns disease location. Gastroenterology 102(4 Part 2): A611
D'argenio, G.; Cosenza, V.; Della Valle, N.; De Ritis, F.; Mazzacca, G.; Riegler, G.; Morace, F.; D'inca, R.; D'odorico, A.; Paoluzi, P.; Di Paolo, M.C.; Annese, V.; Lombardi, G.; Mansi, C.; Caprilli, R.; Taddei, O. 1998: Serum transglutaminase correlates with endoscopical and histopathological grading in patients with ulcerative colitis. Gastroenterology 114(4 Part 2): A959
D'argenio G.; Biancone, L.; Sorrentini, I.; Cosenza, V.; Iovino, P.; Boirivant, M.; Pallone, F.; Mazzacca, G. 1991: Serum transglutaminase in active and quiescent crohns disease a short term longitudinal pilot study. Gastroenterology 100(5 Part 2): A206
D'argenio G.; Sorrentini, I.; Ciacci, C.; Iovino, P.; Gatto, A.; Cosenza, V.; Mazzacca, G. 1990: Serum transglutaminase in patients with intestinal lymphoma and alpha chain disease. Gastroenterology 98(5 Part 2): A277
Rohr, S. 1989: Serum transiently increases the beat rate of cultured neo natal rat heart cells. Experientia 45(ABSTR): A72
Lin, C.Y.; Morel, D.W. 1993: Serum transport of 25-hydroxycholesterol. FASEB Journal 7(3-4): A383
Huffman, F.G.; Duggan, A. 1997: Serum transthyretin in hemodialysis patients Relationship to nutritional status. FASEB Journal 11(3): A190
Yoshida, K.; Mizukawa, H.; Haruki, E. 1993: Serum trehalase activity in patients with rheumatoid arthritis. Clinica Chimica Acta; International Journal of Clinical Chemistry 215(1): 123-124
Kluger, E.K.; Malik, R.; Ilkin, W.J.; Snow, D.; Sullivan, D.R.; Govendir, M. 2008: Serum triglyceride concentration in dogs with epilepsy treated with phenobarbital or with phenobarbital and bromide. Journal of the American Veterinary Medical Association 233(8): 1270-1277
Steindl, P.E.; Kutilek, M.; Novacek, G.; Ferenci, P. 1997: Serum triglyceride increase during interferon treatment of hepatitis C-A frequent finding. Journal of Hepatology 26(Suppl 1): 204
Seidler, D.K.; Mileur, L.M.; Chan, G.M. 1991: Serum triglyceride levels in very low birthweight infants receiving two different intravenous fat emulsions. Clinical Research 39(1): 135A
Smulders, Y.M.; Van Eeden, A.E.; Weijers, R.N.M.; Slaats, E.H.; Silberbusch, J. 1996: Serum triglyceride reduction is associated with slower progression of microalbuminuria in NIDDM patients with hypertriglyceridemia. Diabetologia 39(Suppl 1): A272
Garcia L.; Lodeiro C.; Castro H.; Gomez Bermudez M.C.; Barreiro M.; Hermida R.C.; Sanchez De La Pena S.; Hillman D.C.; Wu J.; Et Al 1990: Serum triglyceride rhythm alteration detected chronobiologically but not conventionally. Chronobiologia 17(2): 167-168
Conroy, R.M. 1993: Serum triglycerides and aggression in the general population. Lancet 341(8838): 176
Tiwari, A.; Khan, S.H.; Singh, A.P.; Baig, H.A.; Raju, B.S. 1998: Serum triglycerides and apo-lipoprotein b A ratio as sensitive predictor for premature coronary artery disease in population with desirable levels of serum cholesterol. Atherosclerosis 136(Suppl ): S58
Salonen, J.T.; Seppanen, K.; Rauramaa, R. 1989: Serum triglycerides and the risk of acute myocardial infarction a population study in eastern finland. European Heart Journal 10(ABSTR Suppl): 159
Stensvold, I.; Tverdal, A.; Graff Iversen, S.; Urdal, P. 1992: Serum triglycerides as risk factor for coronary heart disease mortality in women and men results from a follow up study in norway. European Heart Journal 13(ABSTR Suppl): 106
Lahdenpera, S.; Syvanne, M.; Taskinen, M.R. 1995: Serum triglycerides determine the properties of low density lipoprotein particles in NIDDM and coronary disease. Diabetologia 38(Suppl 1): A249
Kaplan, T.A.; Campbell, M.H.; Moccia, G. 1994: Serum triglycerides do not affect smaller airway reactivity to exercise in obese children and adolescents. Medicine and Science in Sports and Exercise 26(5 Suppl): S208
Bora, A.; Baruah, R.N.; Baruah, K.K.; Bora, R.K.; Goswami, J. 1997: Serum triiodothyronine and thyroxine levels in the young rabbits fed on different levels of concentrate, roughage ratio. Indian Veterinary Journal 74(6): 478-479
Takeuchi, H.; Matsuo, T.; Tokuyama, K.; Suzuki, M. 1994: Serum triiodothyronine levels is lower in rats fed a lard diet compared with in rats fed a high oleic safflower oil, safflower oil and linseed oil diets. FASEB Journal 8(4-5): A171
Goyert, G.L.; Gold, R.B.; Wright, D.J.; Bronsteen, R.A.; Schwartz, D.B.; Grier, R.E. 1998: Serum triple marker screening for trisomy 18 also screens for triploidy. American Journal of Obstetrics and Gynecology 178(1 Part 2): S144
Feng, Y.J.; Wu, A.; Ma, L.; Lai, T.; Waters, D.; Chen, C. 1997: Serum troponin I is more sensitive for the detection of acute ischemic myocardial injury than serum myoglobin or CK-MB. Journal of the American College of Cardiology 29(2 Suppl A): 450A-451A
Franz, W.M.; Remppis, A.; Scheffold, T.; Kandolf, R.; Katsu, H.A. 1994: Serum troponin T A diagnostic marker for acute myocarditis?. Circulation 90(4 Part 2): I67
Jurlander, B.; Molani, M.A.; Balu, D.; Ellis, A.K. 1995: Serum troponin T levels predicts coronary angiographic findings in patients with unstable angina. Circulation 92(8): I679
El-Khuffash, A.F.; Molloy, E.J. 2008: Serum troponin in neonatal intensive care. Neonatology 94(1): 1-7
Joly, J.P.; Sesboue, R.; Hillemand, B.; Martin, J.P. 1990: Serum trypsin like activity sta and c peptide levels in chronic alcoholized men. Alcoholism Clinical and Experimental Research 14(2): 301
Sainio, V.; Puolakkainen, P.; Kemppainen, E.; Hedstrom, J.; Haapiainen, R.; Kivisaari, L.; Stenman, U.; Schroder, T.; Kivilaakso, E. 1995: Serum trypsinogen-2, a new reliable assay for the early diagnosis and prediction of outcome in acute necrotizing pancreatitis. Gastroenterology 108(4 Suppl): A387
Alvarez, M.J.; Acero, S.; Lizaso, M.T.; Olaguibel, J.M.; Garcia, B.E.; Echechipia, S.; Rodriguez, A.; Tabar, A.I. 1996: Serum tryptase in anaphylaxis diagnosis. Allergy 51(Suppl 31): 112
Monafo, V.; De Amici, M.; Lizzoli, F.; Fiocchi, S.; De Giacomo, C. 1998: Serum tryptase levels and in vitro tryptase production by peripheral blood mononuclear cells from four family members with mastocytosis. Allergy 53(Suppl 43): 190
Marshall, G.D.; Calabrese, D.M.; Schwartz, L.B. 1996: Serum tryptase levels in ICU patients with unexplained acute hypotension. Journal of Allergy and Clinical Immunology 97(1 Part 3): 270
Carpenter, G.B.; Hershey, J.N.; Engler, R.J.M.; Davis, W.S.; Smith, L.J.; Salata, K.F. 1992: Serum tryptase levels in adverse reactions in an allergy clinic. Journal of Allergy and Clinical Immunology 89(1 Part 2): 349
Ordogui, E.; Rodriguez, V.; Zubeldia, J.M.; Rubio, M.; Olalde, S.; Gil, P.; Baeza, M.L. 1995: Serum tryptase levels in allergic drug reactions. Journal of Allergy and Clinical Immunology 95(1 Part 2): 172
Carias, K.; Rouse, C.; Schwartz, L.B. 1995: Serum tryptase, a potential screening test for systemic mastocytosis. Journal of Allergy and Clinical Immunology 95(1 Part 2): 294
Elderfield, A.J.; Truscott, R.J. 1994: Serum tryptophan and age-related cataract. Developments in Ophthalmology 26: 52-56
Russell, I.J.; Brown, R.R. 1993: Serum tryptophan and kynurenine in fibromyalgia syndrome , rheumatoid arthritis , osteoarthritis and healthy normal controls. Arthritis and Rheumatism 36(9 Suppl): S223
Beyer, H.S.; Stuart, D.; Ney, A.; Peltier, G. 1989: Serum tsh may be elevated in nonthyroidal illness. Clinical Research 37(2): 356A
Aydiner, A.; Topuz, E.; Dişçi, R.; Yasasever, V.; Dinçer, M.; Dinçol, K.; Bilge, N. 1994: Serum tumor markers for detection of bone metastasis in breast cancer patients. Acta Oncologica 33(2): 181-186
Liu, Frank, J.Feng 1993: Serum tumor marker assays in cancer patient care. Cancer Bulletin 45(1): 55-63
Joura, E.; Gitsch, G.; Kainz, C.; Froehlich, B.; Biegelmayr, C.; Koelbl, H. 1992: Serum tumor markers SCC, TATI and TPS Relevance in postoperative care of women with cervical carcinoma. Gynaekologisch-Geburtshilfliche Rundschau 32(Suppl 1): 115
Frena, A. 1995: Serum tumor markers SPan 1 and CA 242 in pancreatic cancer. Digestion 56(4): 285
Shahangian, S.; Fritsche, H.A.Jr 1989: Serum tumor markers as diagnostic aids in patients with unknown primary tumors. Cancer Bulletin 41(3): 152-156
Haritou, A.; Kolios, G.; Seferiadis, K.; Tsolas, O.; Constantopoulos, S.H. 1997: Serum tumor markers can discriminate between benign and malignant lung disease even when bronchoscopy is not diagnostic. European Respiratory Journal Suppl 10(25): 379S
Fritsche, H.A.; Gelder, F.B. 1990: Serum tumor markers for pancreatic carcinoma. Immunology Series 53: 289-296